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Abstract
This thesis is concerned with the synthesis of novel azo-cinnamates and of
steroidal azo ethers and with the analysis of the spectroscopic and thermal properties
of these materials. The compounds were identified as possible photoswitchable liquid
crystals. The molecules were prepared by multi-step sequences, involving
etherification, azo coupling and Appel-type reactions as the key steps in the case of
the azo-cinnamates, and Finkelstejn reactions and Williamson-type etherification
reactions as the major transformations in the case of the steroidal azo ethers. The
preparation of the azo-cinnamates was a further example of an esterification reaction
run under Appel-type conditions using BrCCl3/PPh3. The azo-cinnamates were shown
to be photoswitchable under photoirradiation at λ = 350 nm, where the thermally stable
trans-azo compounds isomerized photochemically to the cis-isomers. Subsequently,
the energetically less stable cis-isomers isomerized thermally back to the transisomers. The azo-cinnamates were found to exhibit thermotropic liquid crystalline
behavior as evidenced by differential scanning calorimetric analysis and by optical
texture analysis under the polarization microscope of selected samples.
Azocinnamates have been found to exhibit liquid crystalline behavior before, however,
it is commonly accepted that in systems containing three (or more) aromatic rings, in
the compounds that exhibit liquid crystalline (eg., nematic) behavior, the ring systems
normally are positioned in close proximity to each other, preferably with less flexible
linkers connecting them. In the presently studied compounds, however, the cinnamate
unit is separated from the azobenzene substructure by flexible C9- and C11-alkyl
chains, and so it is exciting to see that also these compounds exhibit (albeit in a narrow
temperature range) thermotropic behavior.

Keywords: Azo cinnamates, steroidal azo compounds, photoswitching, liquid
crystals, single X-ray crystal structure.
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)Title and Abstract (in Arabic

تحضير وتحليل ودراسة خصائص مركبات جديدة من ساللة االزوسيناميت
واالزوكوليسترول
الملخص

في هذا البحث تم تحضير مركبات جديدة تصنف ضمن مجموعة ()azo-cinnamates
و مجموعة ( )steroidal azo ethersوتحليلها باستخدام أجهزة تحليل المركبات العضوية.
وأيضا تمت دراسة الخصائص الفيزيائية والحرارية لهذه المركبات .فقد تم تحضير هذه المركبات
عن طريق العديد من التفاعالت الكيميائية من اهمها :تفاعالت تركيب االزو و تفاعالت تركيب
االيثر وتفاعالت االسترة .تم تحليل جميع المركبات والتأكد من نقاوتها بشكل دقيق .بعد دراسة
الخصائص الفيزيائية والضوئية لهذه المواد باستخدام اجهزة تحليل الطيف الضوئي وجهاز الرنين
المغناطيسي النووي وجدت ان هذه المركبات لها القدرة على التحول بين النظائر (النظير سيس
والنظير ترانس) عند تعريضها لألشعة فوق البنفسجية او حتى تعريضها للحرارة .وجدت أيضا
بعد االنتهاء من دراسة الخصائص الحرارية لبعض هذه المواد باستخدام جهاز المجهر الحراري
وجهاز المسح الحراري التفاضلي أن لها خصائص مشابهه لخصائص مركبات الكرستاالت
السائلة.
مفاهيم البحث الرئيسية :الكرستاالت السائلة ،النظائر ،تفاعالت تركيب االيثر ،تفاعالت
االسترة.
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Chapter 1: Introduction
1.1 Overview
In this work, novel photoswitching compounds will be prepared.
Photoswitchable molecules are able to isomerize between at least two metastable
forms through an external stimulus such as photoirradiation (Beharry, Sadovski, &
Woolley, 2011). Originally, these types of molecules found interest in different areas
of science such as in physics, chemistry and biology (Heckel & Mayer, 2010; Russew
& Hecht, 2010; Szobota & Isacoff, 2010; Wyart et al., 2009). The extensive usage of
photochromic molecules, ie., molecules that change color upon photoirradiation, is due
to the general, also commercial interest in two isomers of a molecule having
fundamentally different physical and chemical properties, especially if the different
isomers can be addressed separately. Photoswitchable molecules have a wide range of
applications such as in photo-electric cells. They are also used in the generation of
three-dimensional animations and images and in screen displays (in conjunction with
liquid crystals) (Stranius & Börjesson, 2017).
Photoswitching molecules can be used as dopants in liquid crystalline hosts.
Alternatively, photoswitching compounds can be liquid crystalline themselves. For the
second category, most of molecules are based on an azobenzene as the photoswitching
unit, but p-alkoxy substituted phenylbut-1,3-dien-4-ylbenzonitriles (1) (Davis, Mallia,
& Das, 2003) (Figure 1) as well as the photoactive (-)-2-arylidene-p-menthane-3-one
(2) unit in cholesteric polymeric LCs (Figure 2). (Brehmer, Lub, & Witte, 1998) have
also been used as intrinsically photoactive liquid crystalline formulations (Davis et al.,
2003).
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Figure 1: 1,4-Diphenyl butadiene
derivatives (1)

Figure 2: (-)-2-Arylidene-p-menthane-3-one on a
polymer backbone (2)

Since their discovery by Reinitzer and Lehmann in 1888/1889, liquid crystals
have gained ever-increasing interest, first with the excellent synthetic work of
Vorländer and a first understanding of the different LC phases, then with detailed Xray crystal structural analyses and the elucidation and classification of further
mesophases such as of the smectic liquid crystals in the 1970s/1980s, and finally with
the work on the application of LCs in electro-optical displays, starting with the
investigations carried out at RCA, Princeton, on dynamic scattering displays in the late
1960 (Gray, 1998). The development of ever-new LC incorporating displays continues
unabated.
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The most important mesophases of thermotropic liquid crystals are the
nematic, smectic A, smectic C and columnar discotic phases. Also, two important
chiral phases exist: the cholesteric (chiral nematic) and the smectic C phase (Figure 3).
In addition, a number of blue phases exist. Further new phases have been discovered
over time.

Figure 3: Mesophases of thermotropic liquid crystals

Azobenzenes are the most commonly used photoswitchable LC materials.
Thus, azobenzene derivatives have been utilized in photoresponsive functional devices
in smart polymers (Kawai, Nakashima, & Irie, 2005), in molecular switches (Yasuda,
Nakamura, Matsumoto, & Shigekawa, 2003), in data storage systems (Yager &
Barrett, 2006) and as molecular “machines” in supramolecular organic chemistry
(Beharry & Woolley, 2011; Broichhagen & Trauner, 2014; Goulet‐ Hanssens &
Barrett, 2013). As such, azobenzene derivatives have received considerable
experimental and theoretical attention.
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1.2 Statement of the Problem
The idea was to prepare a series of p-alkoxyazobenzene-cinnamates as
potential photoswitchable guests (dopants) to be used in liquid crystal hosts. Also, it
was to be examined, if it were possible to use p-alkoxyazobenzene-alkanols shown in
Scheme 1 to prepare p-alkoxyazobenzenealkyl cholesteryl ethers as potential chiral
dopants for liquid crystalline phases. Furthermore, it was to be determined whether
these substances themselves would exhibit liquid crystalline behavior. In parallel, the
photoswitching behavior of these materials was to be examined.

Scheme 1: p-alkoxyazobenzene-cinnamates and p-alkoxyazobenzenealkyl
cholesteryl ethers

1.3 Azobenzene based liquid crystals
Azobenzenes can be found as important moieties in the structure of liquid
crystals. Although the science of liquid crystals (LCs) has matured over the years, there
is still interest in developing liquid crystalline material with enhanced properties as
well as liquid crystalline devices that incorporate their formulations.
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Azobenzene exists as two isomers: the E-isomer (or trans-isomer) and the Zisomer (or cis-isomer) (Figure 4). The E-isomer is by 50 kJ mol-1 more stable
thermodynamically than the Z-form. Consequently, the different spatial arrangements
of the different isomers lead to different physical and chemical properties (Ichimura,
Oh, & Nakagawa, 2000).
Azobenzenes can be classified into three general types, depending on their
photophysical response: azobenzenes which are unsubstituted and count as the parent
compounds, aminoazobenzenes which are substituted with an electron donating group
(NH2) and pseudo-stilbenes which are known for their strongly asymmetric electron
distribution (push/pull substitution). The reason behind the strongly asymmetric
pattern of this third group of azobenzenes lies in the fact that they are substituted at 4
and 4' by an electron donating group and an electron withdrawing group, respectively
(Yager & Barrett, 2006).

Figure 4: Reversible trans and cis isomerization of azobenzenes
upon UV irradiation (trans-cis), VIS irradiation (cis-trans) or
thermal treatment (cis-trans)

The structure of E-azobenzene is not planar; the dihedral angle N,N,C,C is
around 17.5°. In contrast, one of the phenyl rings of the Z isomer occupies a plane
tilted by 56° from the plane of the other ring (Figure 5). This leads to a great difference
in the intramolecular distances between the phenyl groups in cis- and trans-

6
azobenzenes. Thus, the distances between the two carbon atoms in the 4-and 4’positions are 9.0 and 5.0 Å for the E- and Z-isomer, respectively (Figure 5) (Hamon,
Djedaini-Pilard, Barbot, & Len, 2009).

Figure 5: Geometrical structures of the E- and Z-isomer of azobenzene (Hamon,
Djedaini-Pilard, Barbot, & Len, 2009)

The UV–visible absorption spectra of E-azobenzene are characterized by three
major bands: (i) a band at λ = 228 nm originates from a π–π* transitions localized on
the phenyl groups; (ii) a band at λ = 318 nm originates from symmetry-allowed π–π*
transitions, from orbitals which are delocalized through the molecule including the two
nitrogen atoms; and (iii) a band at λ = 440 nm originates from symmetry forbidden n–
π* transitions occurring at the central nitrogen atoms (Figure 6). It is notable that the
UV–visible absorption spectrum of the Z-isomer is quite different from that of the Eisomer, with a band at λ = 260 nm originating from symmetry-allowed π–π* transitions
(λ = 318 nm for the E-isomer) (Y. Yang, Hughes, & Aprahamian, 2012). In addition,
any substitution patterns on the azobenzene chromophores can affect the UV
absorption bands, and this will be discussed in detail in the discussion part.
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Figure 6: UV–vis absorption spectra of E- and Zazobenzene (Y. Yang, Hughes, & Aprahamian,
2012)

In this work, the photoisomerization of the synthesized compounds will be
investigated. Photo-reversible switching between trans & cis isomers of the azo
benzene derivatives can be performed by irradiation of the samples with light at
various wavelengths (Figure 6) (Yin, Zhao, & Zhang, 2018). There are many previous
studies which proposed the mechanism of the cis trans isomerization of 4,4`substituted azobenzene derivatives. The first type is the rotation at the –N=N– bond
through π-bond rupture, and the second type is an inversion of one or of both nitrogens
through a linear hybridisation transition state, in which the double bond is retained.
There are many differences between the two isomers such as absorption bands, redox
potential, refractive index and the geometrical structure (these differences will be
discussed further in the discussion part) (Yamaguchi et al., 2005).
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1.4 Relevant Literature
Similar to our novel materials, compounds have been prepared by other
researchers. Those types of compounds exhibit liquid crystalline behavior (LC).
Figures 7, 8, 9, 10 below, show materials structurally similar to our novel, synthesized
compounds. This includes a series of steroidal azo carbonates of type (3) and (6)
(Figures 7 and 8) (Yang et al., 2013). When n= 0 in compound 3 “both cholesterol and
azobenzene moieties are attached to each other by carbonate linkage”, there is an
absence of a mesophase for the compound, while when is n= 6, 11, the compounds
exhibit mesomorphic phases, where the compounds show enantiotropic mesophases
and chiral nematic phases (Figure 7).

Figure 7: Cholesterol azo derivative (3)

Figure 8: Chiral azobenzene dopant (6)
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Compounds that are chiral azobenzenes can be used as a chiral dopant (guest)
in liquid crystalline hosts. Upon the irradiation process, the trans form of azobenzene
can stabilize the LC texture because of its rod-like shape, while the cis form
destabilizes the texture by generating a disorder in the aligned system. The compound
(6) shown in (Figure 8) was used as a chiral dopant in the nematic liquid crystalline 4cyano-4’-pentylbiphenyl (5CB) (7) (Figure 10). The results proved that the cis form of
the chiral dopant destroyed the short-range orientational order of the mesophase
(Figure 10 C) (Wang & Li, 2012).

Figure 9: 4-Cyano-4'-pentylbiphenyl
(5CB) (7)

Figure 10: POM image of the mixture achiral nematic LC host 5CB during cooling
cycle at 38.9 °C (A: before UV irradiation, B: after UV irradiation, C: after the
radiation was stopped) [from Wang & Li, 2012]
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Azo-cinnamates shown in Figures 11 & 12 have been forwarded as liquid
crystals by Selvarasu and Kannan (Selvarasu & Kannan, 2016). A series of these
compounds, shown in Figure 11, exhibit nematic phases in the cooling cycle
proceeding from the isotropic phase. In addition, with increasing carbon chain length,
a focal conical texture characteristic of a Smectic-C mesophase started to appear. Also,
for the compounds shown in Figure 12, nematic and smectic phases were recognized
in the heating and cooling cycles.

Figure 11: Cinnamate aldimine derivative (4)

Figure 12: Cinnamate azo derivative (5)
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1.5 Synthesis
As azobenzene have many applications, they are of great interest to scientists,
especially to synthetic organic chemists. Azobenzenes can be synthesized in six main
ways, which can be classified as: (i) oxidation of aromatic primary amines; (ii)
reduction of aromatic compounds having a nitro group; (iii) coupling of primary
arylamines with nitro compounds (Mills reaction); (iv) electrophilic reactions of
diazonium salts; (v) oxidation of hydrazine derivatives; (vi) reduction of azoxybenzene
derivatives (Hamon et al., 2009) (Figure 13) and (vii) other methods (Merino, 2011).
In this work, we will choose a method analogous to that reported in a previous work
(Yan, et al., 2012).
For specifically our targeted compounds, alkylation of nitrophenol with a 1,ωhaloalkanol is the first step in our synthetic route. To prepare the azobenzenes, the
reduction of the nitro group to aniline is necessary. Under certain conditions, which
we will describe later, in the experimental part, the diazotization step will occur in
good yield. Thereafter, further alkylation of the hydroxyazobenzene intermediate with
a haloalkane will be carried out to get the pen-ultimate building block of our synthesis.
Finally, an esterification (in the case of the azocinnamates) and an etherification (in
the case of the steroidal azo ether) will lead to the target compounds.
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Figure 13: General preparations of azobenzene
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1.6 Potential Contributions and Limitations of the Study
As the linker between the azobenzene and the cinnamate unit in the molecules
is relatively long and flexible, it was predicted that the molecules would exhibit
mesophases only with a relatively narrow temperature range, if at all. In the studies, it
was seen, however, that the compounds analyzed have a rich thermal behavior, even
exhibiting different crystal forms.
As a thermal hotplate – polarization microscope set-up was not available at the
UAEU, the thermal measurements and texture analysis was carried out at the
University of Hamburg, and only a limited investigation of the liquid crystalline
behavior of the compounds could be performed. Here, it is believed that a more
detailed study would be warranted. This is especially true for the use of the steroidal
azobenzene ethers as chiral dopants, where a more complete study of hosts would be
needed. Furthermore, although the photoswitching of the pure compounds was studied,
the change of the alignment of the pure substances in the mesophase under
photoirradiation could not be studied as could also not be studied the behavior of host
phases under photoirradiation in presence of the here-synthesized compounds used as
dopants.
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Chapter 2: Methods
2.1 Research Design

The compounds shown in the thesis were synthesized, purified (using
crystallization or column chromatography), and characterized by 1H NMR, 13C NMR,
DEPT and/or INEPT techniques, LC-MS-MS, and IR spectroscopy. Selected
compounds were analyzed by UV-VIS spectroscopy, and submitted to DSC thermal
analysis and X-ray single crystal structural determination. Selected azo cinnamates
were photoirradiated in an attempt to photo-isomerize the molecules. The progress of
the photoreactions was followed by either UV-VIS or 1H NMR spectroscopy.
Furthermore, a polarization microscope with a hot stage was used to look at the texture
of some of the compounds.
Column chromatography was carried out on commercial 60 Å silica gel (230 –
400 mesh, Merck grade 9385, Sigma Aldrich) and on recycled silica gel (new research
in our research group). Analytical thin layer chromatography (TLC) was carried out
on TLC Alu foils from Fluka (with fluorescent indicator at λ = 254 nm). 1H NMR (at
400 MHz) and
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C NMR (at 100.5 MHz) spectra were taken on a Varian 400 MHz

spectrometer. For some samples, a Bruker Avance 500 spectrometer with a working
frequency of 500 MHz for 1H nuclei was used at NYU-AD. Furthermore, samples were
also measured on a Varian 200 MHz NMR spectrometer (1H at 200.0 MHz, 13C at 50.3
MHz). Infrared spectra were taken on a Thermo Nicolet Nexus 670 FT-IR
spectrometer (solid samples as KBr pellets). UV-VIS spectroscopy was performed on
UV-1800 (Shimadzu). X-ray crystal structural analysis was performed on single
crystals of compounds xx, xx, and xx, utilizing a Bruker APEX DUO diffractometer
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with CCD area detector and monochromatic MoKα radiation (λ= 0.71069) (NYU-AD,
Prof. Panče Naumov). For the photoirradiation, a Luzchem LZC 4V photoreactor was
used with either 13 USHIO G8T5 lamps (7.2 W low pressure mercury arc lamp with
a radiation peak at λ = 253.7 nm) or with 14 Hitachi FL8BL-B (0.75 W, UV irradiance
8.0 (µ/cm)2, with a radiation peak at λ = 352 nm). CH2Cl2 [Sigma Aldrich, purris. p.a.,
≥ 99.9% (GC)] and benzene were taken as solvents in the photoirradiation
experiments. The thermal behavior was investigated using differential scanning
calorimeter (DSC-60, Shimadzu) in the mechanical engineering at UAEU (Prof. Dr.
Abdel-Hamid Mourad). The masses of the synthesized compounds were measured
using an LC-MS-MS 8060 (Shimadzu, with Dr. Iltaf Khan). Textures of selected
samples were investigated using an Olympus BH polarization microscope with a
Mettler-Toledo hotstage.
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2.2 Experimental
General: 1H and 13C NMR spectra were recorded with a Varian 400 NMR (1H
at 395.7 MHz, 13C at 100.5 MHz) and a Varian 200 MHz NMR spectrometer (1H at
200.0 MHz, 13C at 50.3 MHz). The chemical shifts are relative to TMS (solvent CDCl3,
unless otherwise noted). Infrared spectra were taken on a Thermo Nicolet Nexus 670
FT-IR spectrometer (solid samples as KBr pellets). Column chromatography was
carried out on silica gel with Sigma Aldrich 60 Å (230 – 400 mesh, Merck grade 9385).
TLC was performed on TLC foils (Silica gel on TLC alu foils, Fluka 60778-25EA).

2.2.1 First pathway
The compounds, which are prepared in this section, will follow the synthetic
route shown in Figure 14.

(10&15)
(8)

(9&14)

(12-13&17-20)
(11&16)

Figure 14: Synthetic route of the preparation of the alkoxy azobenzene derivatives
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9-(4-Nitrophenoxy)nonan-1-ol (9):
A mixture of 4-nitrophenol (8) (8.6 g, 62 mmol), 11-bromo-1-nonanol (14 g,
62 mmol) and potassium carbonate (8.8 g, 62 mmol) was dissolved in
dimethylformamide (DMF, 50 mL). The resulting solution was heated to 120 °C and
left until the reaction finished. After that, the reaction mixture was cooled down to
room temperature. Then, distilled water (200 mL) was added to the mixture. A yellow
precipitate was formed. The precipitate was collected and extracted with ethyl acetate
(70 mL). The ethyl acetate solution was washed with water (100 mL) and dried over
magnesium sulfate (MgSO4). The organic phase (ethyl acetate) was filtered and
evaporated in vacuo using a rotary evaporator to obtain comp. 9 as a solid (12.9 g,
74%).
δH (400 MHz, CDCl3) 1.27-1.52 (12H, m, CH2), 1.78 (2H, m, CH2), 3.58 (2H,
t, OCH2), 4.00 (2H, t, OCH2), 6.89 (2H, d, CH), 8.14 (2H, d, CH); δC (100.5 MHz,
CDCl3) 25.7 (CH2), 25.9 (CH2), 28.9 (CH2), 29.2 (CH2), 29.3 (CH2), 29.4 (CH2), 32.7
(CH2), 62.8 (OCH2), 68.8 (OCH2), 114.4 (CH), 125.9 (CH), 141.2 (CH), 164.2 (CH).
IR υ (KBr, cm-1): 3021, 2918, 2850, 1608, 1590, 1517, 1473, 1396, 1367, 1242, 1070,
1009, 821, 763.
9-(4-Aminophenoxy)nonan-1-ol (10):
9-(4-Nitrophenoxy)nonan-1-ol

(9) (12.9 g, 46 mmol) was dissolved in

tetrahydrofuran (THF, 80 mL). Then, palladium on carbon (2.4 g, 10 w% Pd/C) was
added to the resulting solution. After that, hydrogen gas was added using a balloon.
The reaction mixture was stirred, until the reaction finished (typically, 72 h). After the
reaction finished, the reaction mixture was filtered over Celite (5 g) to remove the
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Pd/C. Then, the solvent was removed in vacuo using a rotary evaporator to obtain 10
as a solid (8.25 g, 72%).
δH (400 MHz, CDCl3) 1.31-1.56 (12H, m, CH2), 1.72 (2H, m, CH2), 3.61 (2H,
t, OCH2), 3.86 (2H, t, OCH2), 6.63 (2H, d, CH), 6.73 (2H, d, CH); δC (100.5 MHz,
CDCl3) 25.7 (CH2), 26.0 (CH2), 29.3 (CH2) 29.3 (CH2), 29.4 (CH2), 29.5 (CH2), 32.8
(CH2), 62.0 (OCH2), 68.6 (OCH2), 115.6 (CH), 116.4 (CH), 139.7 (CH), 152.3 (CH).
IR υ (KBr, cm-1): 3526, 3113, 3089, 2918, 2850, 1604, 1592, 1501, 1472, 1346, 1307,
1261, 1184, 1116, 1047, 1006, 857, 753, 660.
4-((4-((9-Hydroxynonyl)oxy)phenyl)diazenyl)phenol (11):
(10) (8.25 g, 32.9 mmol) was dissolved in hydrochloric acid (160 mL, 1 M),
and the resulting solution was cooled to 0 °C. With stirring, a solution of sodium nitrite
(2.27 g, 32.9 mmol) in water (18 mL) was added dropwise to the solution to produce
the diazonium salt. Then, a mixture of phenol (3.1 g, 32.9 mmol) and sodium
hydroxide (1.3 g, 32.9 mmol) in water (18 mL) was added slowly to the solution, at 0
°C. An aqueous solution of potassium carbonate was added to the mixture to give pH
= 8, and then a yellow solid precipitated. The reacting mixture was stirred further at 0
°C and left, until the reaction finished. After the reaction finished, hydrochloric acid
(1 M) was added to the reacting mixture to give pH = 4. The yellow solid precipitate
was collected and washed with water. The crude product was re-crystallized from
ethanol to give 11 as a solid (5.18 g, 45.6%).
δH (400 MHz, DMSO) 1.23-1.37 (16H, m, CH2), 1.69 (2H, m, CH2), 3.34 (2H,
t, OCH2), 4.01 (2H, t, OCH2), 6.89 (2H, d, CH), 7.04 (2H, d, CH), 7.71 (2H, d, CH),
7.76 (2H, d, CH); δC (100.5 MHz, DMSO) 25.9 (CH2), 26.1 (CH2), 29.0 (CH2), 29.0
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(CH2), 29.2 (CH2), 29.3 (CH2) 29.3 (CH2), 29.5 (CH2), 32.9 (CH2), 61.2 (OCH2), 68.3
(OCH2), 115.3 (CH), 116.2 (CH), 124.4 (CH), 124.8 (CH), 145.6 (CH), 146.5 (CH)
160.6 (CH), 161.1 (CH). IR υ (KBr, cm-1): 3370, 2938, 2853, 1593, 1562, 1503, 1471,
1257, 1145, 1020, 846.
9-(4-((4-(Hexyloxy)phenyl)diazenyl)phenoxy)nonan-1-ol (12):
A mixture of (11) (5.18 g, 15 mmol), 1-bromohexane (2.39 g, 15 mmol) and
potassium carbonate (2.07 g, 15 mmol) was dissolved in dimethylformamide (13 mL).
The resulting solution was heated at 120 °C and left it until the reaction finished. After
that, the mixture cooled to room temperature. Then, distilled water (100 mL) was
added to the mixture, and a yellow precipitate formed. The precipitate was collected
and extracted with ethyl acetate (100 mL). The ethyl acetate solution was washed with
water and dried over magnesium sulfate (MgSO4). The organic phase (ethyl acetate)
was filtered from the sulfate (MgSO4) and evaporated in vacuo using the rotary
evaporator to obtain 12 as a solid (5.2 g, 62%).
δH (400 MHz, CDCl3) 0.91 (3H, t, CH3), 1.34-1.56 (24H, m, CH2), 1.80 (2H,
m, CH2), 3.63 (2H, t, OCH2), 4.02 (4H, t, OCH2), 6.98 (4H, d, CH), 7.86 (4H, d, CH);
δC (100.5 MHz, CDCl3) 1.1 (CH3), 22.6 (CH2), 25.7 (CH2), 25.9 (CH2), 26.0 (CH2),
26.1 (CH2), 29.0 (CH2), 29.0 (CH2), 29.2 (CH2), 29.3 (CH2), 29.3 (CH2) 29.3 (CH2),
29.5 (CH2), 32.9 (CH2), 63.0 (OCH2), 68.3 (OCH2), 68.3 (OCH2), 114.6 (CH), 124.3
(CH), 146.9 (CH) 161.1 (CH). IR υ (KBr, cm-1): 3349, 2934, 2850, 1602, 1581, 1497,
1474, 1247, 1150, 1027, 843, 555.
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9-(4-((4-(Heptyloxy)phenyl)diazenyl)phenoxy)nonan-1-ol (13):
A mixture of 11 (3 g, 8.42 mmol), 1-bromoheptane (1.8 g, 10.1 mmol) and
potassium carbonate (1.3 g, 10.1 mmol) was dissolved in dimethylformamide (DMF,
12 mL). The resulting solution was heated at 120 °C, and it was left it until the reaction
finished. After that, the mixture was cooled to room temperature. Then, distilled water
(70 mL) was added to the mixture, and a yellow precipitate formed. The precipitate
was collected and extracted with ethyl acetate (100 mL). The ethyl acetate solution
was washed with water and dried over magnesium sulfate (MgSO4). The organic phase
(ethyl acetate) was filtered from the sulfate (MgSO4) and evaporated in vacuo using
the rotary evaporator to obtain 13 as a solid (2.1 g, 56.[5]%).
δH (400 MHz, CDCl3) 0.89 (3H, t, CH3), 1.29-1.58 (24H, m, CH2), 1.80 (2H,
m, CH2), 3.64 (2H, t, OCH2), 4.02 (4H, t, OCH2), 6.98 (4H, d, CH), 7.85 (4H, d, CH);
δC (100.5 MHz, CDCl3) 14.1 (CH3), 22.6 (CH2), 25.7 (CH2), 25.9 (CH2), 29.1 (CH2),
29.2 (CH2), 29.2 (CH2), 29.3 (CH2) 29.3 (CH2), 29.5 (CH2), 31.8 (CH2), 32.8 (CH2),
63.1 (OCH2), 68.3 (OCH2), 68.3 (OCH2), 114.6 (CH), 124.3 (CH), 146.9 (CH) 161.1
(CH). IR υ (KBr, cm-1): 3351, 2935, 2850, 1602, 1581, 1497, 1250, 1151, 1021, 843,
559.
11-(4-Nitrophenoxy)undecan-1-ol (14):
A mixture of 4-nitrophenol (8) (6.68 g, 48 mmol), 11-bromo-1-nonanol (12.06
g, 48 mmol) and potassium carbonate (6.66 g, 48 mmol) was dissolved in
dimethylformamide (DMF, 40 mL). The resulting solution was heated at 120 °C and
left until the reaction finished. After that, the mixture was cooled to room temperature.
Then, distilled water (200 mL) was added to the mixture and a yellow precipitate
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formed. The precipitate was collected and extracted with ethyl acetate (100 mL). The
ethyl acetate solution was washed with water and dried over magnesium sulfate
(MgSO4). The organic phase (ethyl acetate) was filtered from the sulfate (MgSO4) and
evaporated in vacuo using the rotary evaporator to obtain 14 as a solid (13.0 g,
92.(5)%).
δH (400 MHz, CDCl3) 1.27-1.82 (18H, m, CH2), 3.61 (2H, t, OCH2), 4.01 (2H,
t, OCH2), 6.91 (2H, d, CH), 8.17 (2H, d, CH); δC (100.5 MHz, CDCl3) 25.7 (CH2),
25.9 (CH2), 28.9 (CH2), 29.2 (CH2), 29.2 (CH2), 29.3 (CH2) 29.3 (CH2), 29.4 (CH2),
32.7 (CH2), 62.8 (OCH2), 68.8 (OCH2), 114.4 (CH), 125.9 (CH), 141.2 (CH), 164.2
(CH). IR υ (KBr, cm-1): 3088, 2917, 2849, 1604, 1591, 1500, 1471, 1345, 1306, 1260,
1183, 1005, 856, 753.
11-(4-Aminophenoxy)undecan-1-ol (15):
14 (13 g, 42 mmol) was dissolved in tetrahydrofuran (THF, 80 mL), then
palladium on carbon (Pd/C 10 w%, 2.2 g) was added to the resulting solution. After
that, hydrogen gas was added using a balloon. The reaction mixture was stirred at room
temperature until the reaction finished (72 h). After the reaction finished, the reaction
mixture was filtered over Celite to remove the Pd/C. Then, the solvent was removed
usinga rotary evaporator to obtain 15 as a solid (9.5 g, 81%).
δH (400 MHz, CDCl3) 1.26-1.72 (18H, m, CH2), 3.61 (2H, t, OCH2), 3.84 (2H,
t, OCH2), 6.61 (2H, d, CH), 6.71 (2H, d, CH); δC (100.5 MHz, CDCl3) 25.7 (CH2),
25.9 (CH2), 28.9 (CH2), 29.2 (CH2), 29.2 (CH2), 29.3 (CH2) 29.3 (CH2), 29.4 (CH2),
32.7 (CH2), 62.8 (OCH2), 68.8 (OCH2), 115.6 (CH), 116.4 (CH), 141.2 (CH), 164.2
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(CH). IR υ (KBr, cm-1): 3526, 3113, 3089, 2918, 2850, 1604, 1592, 1501, 1472, 1346,
1307, 1261, 1184, 1116, 1047, 1006, 857, 753, 660.
4-((4-((11-Hydroxyundecyl)oxy)phenyl)diazenyl)phenol (16):
15 (3.18 g, 11.39 mmol) was dissolved in hydrochloric acid (1 M, 160 mL),
and the resulting solution was cooled at 0 °C. With stirred, A solution of sodium nitrite
(0.79g, 11.39 mmol) in water (10 mL) was added dropwise into the solution to produce
diazonium salt. A mixture of phenol (1.07 g, 11.39 mmol) and sodium hydroxide (0.46
g, 11.39 mmol) in water (10mL) was added to the solution slowly at 0 °C. An aqueous
solution of potassium carbonate was added to the mixture to give pH = 8, and then a
yellow solid precipitated. The reacting mixture was stirred at 0 °C and leave it until
the reaction finish. After reaction finished, hydrochloric acid (1 M) was added to the
reacting mixture to give pH = 4. The yellow solid precipitation was collected and
washed with water. The crude product was re-crystallized from ethanol to give comp.
16 (2.1 g).
δH (400 MHz, DMSO): 1.22-1.71 (18H, m, CH2), 3.34 (2H, t, OCH2), 4.01
(2H, t, OCH2), 6.89 (2H, d, CH), 7.04 (2H, d, CH), 7.71 (2H, d, CH), 7.76 (2H, d, CH),
10.20 (OH); δC (100.5 MHz, DMSO): 25.9 (CH2), 25.9 (CH2), 29.0 (CH2), 29.2 (CH2),
29.4 (CH2) 29.4 (CH2), 29.5 (CH2), 33.0 (CH2), 61.2 (OCH2), 68.3 (OCH2), 115.3
(CH), 116.3 (CH), 124.4 (CH), 124.8 (CH), 145.6 (CH), 146.5 (CH) 160.7 (CH), 161.1
(CH). IR υ (KBr, cm-1): 3411, 2918, 2849, 1696, 1682, 1500, 1470, 1242, 1145, 1015,
845, 549.
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11-(4-((4-(Hexyloxy)phenyl)diazenyl)phenoxy)undecan-1-ol (17):
A mixture of 16 (1.68 g, 4.37 mmol), 1-bromohexane (0.86 g, 5.23 mmol) and
potassium carbonate (0.72 g, 5.23 mmol) was dissolved in dimethylformamide (DMF,
8 mL). The resulting solution was heated at 120 °C and left until the reaction finished.
After that, the mixture was cooled to room temperature. Thereafter, distilled water (70
mL) was added to the mixture, and a yellow precipitate formed. The precipitate was
collected and extracted with ethyl acetate (100 mL). The ethyl acetate solution was
washed with water and dried over magnesium sulfate (MgSO4). The organic phase
(ethyl acetate) was filtered from the sulfate (MgSO4) and evaporated in vacuo using
the rotary evaporator to obtain 17 as a solid (0.49 g).
δH (400 MHz, CDCl3): 0.91 (3H, t, CH3), 1.3-1.82 (26H, m, CH2), 3.64 (2H, t,
OCH2), 4.03 (4H, t, OCH2), 6.98 (4H, d, CH), 7.86 (4H, d, CH); δC (100.5 MHz,
CDCl3): 14.1 (CH3), 22.6 (CH2), 25.7 (CH2), 25.7 (CH2), 26.0 (CH2), 29.2 (CH2), 29.2
(CH2), 29.4 (CH2), 29.4 (CH2), 29.5 (CH2) 29.5 (CH2), 29.6 (CH2), 31.6 (CH2), 32.8
(CH2), 63.1 (OCH2), 68.3 (OCH2), 68.3 (OCH2), 114.6 (CH), 124.3 (CH), 146.8 (CH)
161.2 (CH). IR υ (KBr, cm-1): 3350, 2955, 2919, 2849, 1602, 1681, 1498, 1473, 1394,
1248, 1151, 1025, 843, 554.
11-(4-((4-propoxyphenyl)diazenyl)phenoxy)undecan-1-ol (18):
A mixture of (16) (0.65 g, 1.7 mmol), 1-bromo-propane (0.67 g, 2.03 mmol)
and potassium carbonate (0.28 g, 2.03 mmol) was dissolved in dimethylformamide
(DMF, 5 mL). The resulting solution was heated at 120 °C and left until the reaction
finished. After that, it was cooled down to room temperature. Then, distilled water
(100 mL) was added to the mixture, and a yellow precipitate was formed. The
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precipitate was collected and extracted with ethyl acetate (100 mL). The ethyl acetate
solution was washed with water and dried over magnesium sulfate (MgSO4). The
organic phase (ethyl acetate) was filtered from the sulfate (MgSO4) and evaporated in
vacuo using the rotary evaporator to obtain 18 as a solid (0.39 g).
δH (400 MHz, CDCl3): 0.91 (3H, t, CH3), 1.3-1.82 (26H, m, CH2), 3.64 (2H, t,
OCH2), 4.03 (4H, t, OCH2), 6.98 (4H, d, CH), 7.86 (4H, d, CH); δC (100.5 MHz,
CDCl3): 13.9 (CH3), 19.2 (CH2), 25.7 (CH2), 26.0 (CH2), 29.1 (CH2), 29.3 (CH2) 29.3
(CH2), 29.5 (CH2), 31.2 (CH2), 32.8 (CH2), 63.1 (OCH2), 68.1 (OCH2), 68.4 (OCH2),
114.8 (CH), 124.8 (CH), 145.8 (CH) 161.7 (CH). IR υ (KBr, cm-1): 3353, 2958, 1918,
2849, 1602, 1581, 1497, 1243, 1150, 844, 554.
11-(4-((4-Butoxyphenyl)diazenyl)phenoxy)undecan-1-ol (19):
A mixture of 16 (1.57 g, 4.08 mmol), 1-bromo-butane (0.67 g, 4.88 mmol) and
potassium carbonate (0.67 g, 4.88 mmol) was dissolved in Dimethylformamide (DMF,
7mL). The resulting solution was heated at 120 °C and left, until the reaction finished.
After that, the reaction mixture was cooled to room temperature. Then, distilled water
(60 mL) was added to the mixture, and a yellow precipitate formed. The precipitate
was collected and extracted with ethyl acetate (100 mL). The ethyl acetate solution
was washed with water and dried over magnesium sulfate (MgSO4). The organic phase
(ethyl acetate) was filtered from the sulfate (MgSO4) and evaporated in vacuo using
the rotary evaporator to obtain 19 as a solid (0.97 g).
δH (400 MHz, CDCl3): 1.06 (3H, t, CH3), 1.26-1.87 (20H, m, CH2), 3.64 (2H,
t, OCH2), 4.04 (4H, t, OCH2), 6.99 (4H, d, CH), 7.94 (4H, d, CH); δC (100.5 MHz,
CDCl3): 10.5 (CH3), 22.5 (CH2), 25.7 (CH2), 26.0 (CH2), 29.2 (CH2), 29.4 (CH2) 29.4
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(CH2), 29.4 (CH2), 29.5 (CH2), 29.5 (CH2), 29.6 (CH2), 32.8 (CH2), 63.1 (OCH2), 68.4
(OCH2), 69.9 (OCH2), 114.8 (CH), 124.7 (CH), 146 (CH) 161.6 (CH). IR υ (KBr, cm1

): 3350, 2958, 2918, 2849, 1602, 1581, 1497, 1243, 1150, 844, 554.

11-(4-((4-(Octyloxy)phenyl)diazenyl)phenoxy)undecan-1-ol (20):
A mixture of 16 (0.8 g, 2.08 mmol), 1-bromo-octane (0.48 g, 2.49 mmol) and
potassium carbonate (0.34 g, 2.49 mmol) was dissolved in dimethylformamide (DMF,
6 mL). The resulting solution was heated at 120 °C and left until the reaction finished.
After that, the mixture was cooled down to room temperature. Then, distilled water
(50 mL) was added to the mixture, and a yellow precipitate formed. The precipitate
was collected and extracted with ethyl acetate (100 mL). The ethyl acetate solution
was washed with water and dried over magnesium sulfate (MgSO4). The organic phase
(ethyl acetate) was filtered from the sulfate (MgSO4) and evaporated in vacuo using
the rotary evaporator to obtain 20 as a solid (0.64 g).
δH (400 MHz, CDCl3): 0.88 (3H, t, CH3), 1.24-1.84 (30H, m, CH2), 3.63 (2H,
t, OCH2), 4.02 (4H, t, OCH2), 6.98 (4H, d, CH), 7.87 (4H, d, CH); δC (100.5 MHz,
CDCl3): 14.1 (CH3), 22.7 (CH2), 25.7 (CH2), 26.0 (CH2), 26.0 (CH2), 29.2 (CH2), 29.2
(CH2) 29.2 (CH2), 29.4 (CH2), 29.4 (CH2), 29.5 (CH2), 29.5 (CH2), 29.6 (CH2), 31.8
(CH2), 32.8 (CH2), 63.1 (OCH2), 68.3 (OCH2), 68.3 (OCH2), 114.7 (CH), 124.4 (CH),
146.7 (CH) 161.2 (CH). IR υ (KBr, cm-1): 33549, 2954, 2919, 2849, 1602, 1681, 1498,
1473, 1248, 1151, 843, 554.
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2.2.2 Second pathway
The following preparations were carried out according to Figure 15.

(12-13&17-20)

(21-36)

Figure 15: Appel-type esterification reaction in order to synthesis azo cinnamates

9-(4-((E)-(4-(Hexyloxy)phenyl)diazenyl)phenoxy)nonyl cinnamate (21):
To a solution of triphenylphosphine (PPh3, 970 mg, 3.70 mmol) in dry CH2Cl2
(15 mL) was added dropwise bromotrichloromethane (BrCCl3, 720 mg, 3.63 mmol)
and the resulting solution was stirred at rt for 25 min, during which it turned yellowbrown. Thereafter, cinnamic acid (460 mg, 3.1 mmol) was added, and the mixture was
stirred at reflux temperature for 30 min. Then, 12 (619 mg, 1.4 mmol) was added, and
the mixture was stirred at reflux for an additional 14h. The cooled solution was
submitted directly to column chromatography on silica gel (CH2Cl2) to give 21 (660
mg, 82%) as a yellow solid.
δH (400 MHz, CDCl3) 0.92 (3H, t, CH3), 1.34-1.84 (22H, m, CH2), 4.02 (4H,
t, OCH2), 4.21 (2H, t, OCH2), 6.45 (1H, d, CH), 6.98 (4H, d, CH), 7.38 (3H, t, CH),
7.54 (2H, d, CH), 7.69 (1H, d, CH) 7.86 (4H, d, CH); δC (100.5 MHz, CDCl3) 14.1
(CH3), 22.6 (CH2), 25.7 (CH2), 26.0 (CH2), 26.0 (CH2), 28.7 (CH2), 29.2 (CH2), 29.2
(CH2), 29.2 (CH2), 29.3 (CH2), 29.4 (CH2), 31.6 (CH2), 64.7 (OCH2), 68.3 (OCH2),
68.3 (OCH2), 114.6 (CH), 118.2 (CH), 124.3 (CH), 128.0 (CH), 128.9 (CH), 130.2
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(CH), 134.4 (CH), 144.6 (CH), 146.9 (CH), 161.1 (CH), 167.1 (C=O). υ IR (KBr, cm1

): 2921, 2852, 1709, 1637, 1603, 1579, 1500, 1473, 1331, 1311, 1245, 1179, 1146,

1027, 844. Mass found: 571 (M+).
(E)-9-(4-((E)-(4-(Hexyloxy)phenyl)diazenyl)phenoxy)nonyl3-(4-methoxyphenyl)
acrylate (22):
To a solution of triphenylphosphine (PPh3, 1.15 g, 4.39 mmol) in dry CH2Cl2
(15 mL) was added dropwise bromotrichloromethane (BrCCl3, 855 mg, 4.31 mmol)
and the resulting solution was stirred at rt for 25 min, during which it turned yellowbrown. Thereafter, 3-(4-methoxyphenyl) acrylic acid (655 mg, 3.68 mmol) was added,
and the mixture was stirred at reflux temperature for 30 min. Then, (12) (735 mg, 1.67
mmol) was added, and the mixture was stirred at reflux for an additional 14h. The
cooled solution was submitted directly to column chromatography on silica gel
(CH2Cl2) to give 22 (815 mg, 81.(5) %) as a yellow solid.
δH (400 MHz, CDCl3) 0.91 (3H, t, CH3), 1.36-1.84 (22H, m, CH2), 3.82 (3H,
t, OCH3), 4.02 (4H, t, OCH2), 4.19 (2H, t, OCH2), 6.31 (1H, d, CH), 6.89 (2H, d, CH),
6.98 (4H, d, CH), 7.47 (2H, d, CH), 7.64 (1H, d, CH), 7.86 (4H, d, CH); δC (100.5
MHz, CDCl3) 14.0 (CH3), 22.6 (CH2), 25.7 (CH2), 26.0 (CH2), 26.0 (CH2), 28.7 (CH2),
29.1 (CH2), 29.2 (CH2), 29.2 (CH2), 29.3 (CH2) 29.4 (CH2), 31.6 (CH2), 55.4
(OCH2), 64.5 (OCH2), 68.3 (OCH2), 68.3 (OCH2), 114.3 (CH), 114.7 (CH), 115.7
(CH), 124.5 (CH), 127.1 (CH), 129.7 (CH), 144.2 (CH), 146.4 (CH), 161.3 (CH),
161.3 (CH), 167.4 (C=O). υ IR (KBr, cm-1): 2936, 2856, 1703, 1634, 1602, 1581, 1514,
1497, 1474, 1243, 1176, 1150, 1025, 843. Mass found: 601 (M+).

28
(E)-9-(4-((E)-(4-(Hexyloxy)phenyl)diazenyl)phenoxy)nonyl-3-(3,4-dimethoxy
phenyl)acrylate (23):
To a solution of triphenylphosphine (PPh3, 970 mg, 3.70 mmol) in dry CH2Cl2
(15 mL) was added dropwise bromotrichloromethane (BrCCl3, 720 mg, 3.63 mmol)
and the resulting solution was stirred at rt for 25 min, during which it turned yellowbrown. Thereafter, 3-(3,4-dimethoxyphenyl) acrylic acid (640 mg, 3.27 mmol) was
added, and the mixture was stirred at reflux temperature for 30 min. Then, (12) (600
mg, 1.36 mmol) was added, and the mixture was stirred at reflux for an additional 14h.
The cooled solution was submitted directly to column chromatography on silica gel
(CH2Cl2) to give 23 (853 mg, 99%) as a yellow solid.
δH (400 MHz, CDCl3) 0.89 (3H, t, CH3), 1.29-1.84 (22H, m, CH2), 3.91 (6H,
s, OCH3), 4.02 (4H, t, OCH2), 4.19 (2H, t, OCH2), 6.31 (1H, d, CH), 6.85 (1H, d, CH),
6.98 (4H, d, CH), 7.05 (1H, d, CH), 7.10 (1H, dd, CH), 7.62 (1H, d, CH), 7.87 (4H, d,
CH); δC (100.5 MHz, CDCl3) 14.1 (CH3), 22.6 (CH2), 26.0 (CH2), 28.8 (CH2), 29.1
(CH2), 29.2 (CH2) 29.2 (CH2), 29.3 (CH2), 29.4 (CH2), 31.8 (CH2), 55.9 (OCH3), 56.0
(OCH3), 64.6 (OCH2), 68.3 (OCH2), 68.3 (OCH2), 109.4 (CH), 110.9 (CH), 114.7
(CH), 115.9 (CH), 122.6 (CH), 124.4 (CH), 127.4 (CH), 144.5 (CH), 146.6 (CH),
149.1 (CH), 151.0 (CH), 161.2 (CH), 161.3 (CH), 161.3 (CH), 167.4 (C=O). υ IR
(KBr, cm-1): 2921, 2853, 1703, 1630, 1600, 1579, 1514, 1500, 1473, 1254, 1137, 1023,
842. Mass found: 631 (M+).
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(E)-9-(4-((E)-(4-(Hexyloxy)phenyl)diazenyl)phenoxy)nonyl 3-(4-(heptyloxy)
phenyl)acrylate (24):
To a solution of triphenylphosphine (PPh3, 810 mg, 3.09 mmol) in dry CH2Cl2
(15 mL) was added dropwise bromotrichloromethane (BrCCl3, 600 mg, 3.03 mmol)
and the resulting solution was stirred at rt for 25 min, during which it turned yellowbrown. Thereafter, 3-(4-(heptyloxy)phenyl)acrylic acid (670 mg, 2.56 mmol) was
added, and the mixture was stirred at reflux temperature for 30 min. Then, (12) (500
mg, 1.38 mmol) was added, and the mixture was stirred at reflux for an additional 14h.
The cooled solution was submitted directly to column chromatography on silica gel
(CH2Cl2) to give (24) (587 mg, 52%) as a yellow solid.
δH (400 MHz, CDCl3) 0.87 (6H, t, CH3), 1.28-1.81 (32H, m, CH2), 3.95 (2H,
t, OCH2), 4.01 (4H, t, OCH2), 4.17 (2H, d, CH), 6.28 (1H, d, CH), 6.86 (2H, d, CH),
6.97 (4H, d, CH), 7.44 (2H, d, CH), 7.61 (1H, d, CH), 7.88 (4H, d, CH); δC (100.5
MHz, CDCl3) 14.0 (CH3), 14.1 (CH3), 22.6 (CH2), 25.7 (CH2), 25.9 (CH2), 26.0 (CH2),
28.7 (CH2), 29.0 (CH2), 29.1 (CH2) 29.2 (CH2), 29.2 (CH2), 29.3 (CH2), 29.4 (CH2),
31.6 (CH2), 31.7 (CH2), 64.5 (OCH2), 68.1 (OCH2), 68.3 (OCH2), 68.3 (OCH2), 114.6
(CH), 114.7 (CH), 114.7 (CH), 115.5 (CH), 124.4 (CH), 124.4 (CH), 124.5 (CH),
126.9 (CH), 129.7 (CH), 144.3 (CH), 160.9 (CH), 167.5 (C=O). υ IR (KBr, cm-1):
2921, 2854, 1708, 1632, 1603, 1578, 1510, 1474, 1249, 1171, 1145, 1023, 840. Mass
found: 685 (M+).
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(E)-9-(4-((E)-(4-(Hexyloxy)phenyl)diazenyl)phenoxy)nonyl 3-(4-bromophenyl)
acrylate (25):
To a solution of triphenylphosphine (PPh3, 970 mg, 3.70 mmol) in dry CH2Cl2
(15 mL) was added dropwise bromotrichloromethane (BrCCl3, 720 mg, 3.63 mmol)
and the resulting solution was stirred at rt for 25 min, during which it turned yellowbrown. Thereafter, 3-(4-bromophenyl)acrylic acid (694.77 mg, 3.06 mmol) was added,
and the mixture was stirred at reflux temperature for 30 min. Then, (12) (608 mg, 1.38
mmol) was added, and the mixture was stirred at reflux for an additional 14h. The
cooled solution was submitted directly to column chromatography on silica gel
(CH2Cl2) to give (25) (890 mg, 94%) as a yellow solid.
δH (400 MHz, CDCl3) 0.89 (3H, t, CH3), 1.34-1.83 (22H, m, CH2), 4.00 (4H,
t, OCH2), 4.17 (2H, t, OCH2), 6.41 (1H, d, CH), 6.96 (4H, d, CH), 7.36 (2H, d, CH),
7.49 (2H, d, CH), 7.59 (1H, d, CH), 7.85 (4H, d, CH); δC (100.5 MHz, CDCl3) 14.0
(CH3), 23.0 (CH2), 25.7 (CH2), 25.9 (CH2), 26.0 (CH2), 28.7 (CH2), 29.1 (CH2), 29.2
(CH2) 29.3 (CH2), 29.4 (CH2), 31.6 (CH2), 64.8 (OCH2), 68.3 (OCH2), 68.3 (OCH2),
114.7 (CH), 118.9 (CH), 124.4 (CH), 124.5 (CH), 124.5 (CH), 129.4 (CH), 132.1
(CH), 133.3 (CH), 143.2 (CH), 146.3 (CH), 146.3 (CH), 146.4 (CH), 161.3 (CH),
161.4 (CH), 161.4 (CH), 166.8 (C=O). υ IR (KBr, cm-1): 2924, 2850, 1706, 1599,
1583, 1501, 1474, 1330, 1315, 1252, 1147, 1022, 841, 548. Mass found: 649 (M+).
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(E)-9-(4-((E)-(4-(Hexyloxy)phenyl)diazenyl)phenoxy)nonyl 3-(anthracen-9yl)acrylate (26):
To a solution of triphenylphosphine (PPh3, 970 mg, 3.70 mmol) in dry CH2Cl2
(15 mL) was added dropwise bromotrichloromethane (BrCCl3, 720 mg, 3.63 mmol)
and the resulting solution was stirred at rt for 25 min, during which it turned yellowbrown. Thereafter, 3-(anthracen-9-yl)acrylic acid (770 mg, 3.10 mmol) was added, and
the mixture was stirred at reflux temperature for 30 min. Then, 12 (608 mg, 1.38 mmol)
was added, and the mixture was stirred at reflux for an additional 14h. The cooled
solution was submitted directly to column chromatography on silica gel (CH2Cl2) to
give (26) (870 mg, 94%) as a yellow solid.
δH (400 MHz, CDCl3) 0.83 (3H, t, CH3), 1.24-1.76 (22H, m, CH2), 3.93 (4H,
t, OCH2), 4.24 (2H, t, OCH2), 6.35 (1H, d, CH), 6.98 (4H, d, CH), 7.91 (4H, dd, CH),
8.00 (2H, d, CH), 8.22 (2H, d, CH) 8.44 (1H, s, CH), 8.62 (1H, d, CH); δC (100.5 MHz,
CDCl3) 14.1 (CH3), 22.6 (CH2), 25.7 (CH2), 26.0 (CH2), 26.0 (CH2), 28.7 (CH2), 29.2
(CH2), 29.2 (CH2), 29.3 (CH2), 29.3 (CH2), 29.5 (CH2), 31.6 (CH2), 65.0 (OCH2), 68.2
(OCH2), 68.3 (OCH2), 114.6 (CH), 124.3 (CH), 125.2 (CH), 125.4 (CH), 126.3 (CH),
127.2 (CH), 128.2 (CH), 128.8 (CH), 129.3 (CH), 129.3 (CH), 131.2 (CH), 141.9
(CH), 146.8 (CH), 161.1 (CH), 161.6 (CH), 166.6 (C=O). υ IR (KBr, cm-1): 2935,
2851, 1707, 1601, 1580, 1500, 1472, 1311, 1266, 1246, 1178, 1145, 1017, 843, 730.
Mass found: 671 (M+).
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9-(4-((E)-(4-(Heptyloxy)phenyl)diazenyl)phenoxy)nonyl cinnamate (27):
To a solution of triphenylphosphine (PPh3, 970 mg, 3.70 mmol) in dry CH2Cl2
(15 mL) was added dropwise bromotrichloromethane (BrCCl3, 720 mg, 3.63 mmol)
and the resulting solution was stirred at rt for 25 min, during which it turned yellowbrown. Thereafter, cinnamic acid (450 mg, 3.04 mmol) was added, and the mixture
was stirred at reflux temperature for 30 min. Then, 13 (588 mg, 1.30 mmol) was added,
and the mixture was stirred at reflux for an additional 14h. The cooled solution was
submitted directly to column chromatography on silica gel (CH2Cl2) to give 27 (630
mg, 83%) as a yellow solid.
δH (400 MHz, CDCl3) 0.89 (3H, t, CH3), 1.31-1.83 (24H, m, CH2), 4.02 (4H,
t, OCH2), 4.10 (2H, t, OCH2), 6.44 (1H, d, CH), 6.98 (4H, d, CH), 7.37 (3H, t, CH),
7.52 (2H, d, CH), 7.68 (1H, d, CH) 7.93 (4H, d, CH); δC (100.5 MHz, CDCl3) 14.1
(CH3), 22.6 (CH2), 25.9 (CH2), 26.0 (CH2), 28.7 (CH2), 29.1 (CH2), 29.2 (CH2), 29.2
(CH2) 29.2 (CH2), 29.3 (CH2), 29.4 (CH2), 31.8 (CH2), 64.7 (OCH2), 68.3 (OCH2),
68.4 (OCH2), 114.8 (CH), 118.2 (CH), 124.7 (CH), 124.7 (CH), 128.0 (CH), 128.9
(CH), 130.2 (CH), 144.4 (CH), 144.6 (CH), 167.1 (C=O). υ IR (KBr, cm-1): 2937,
2852, 1709, 1642, 1599, 1504, 1473, 1332, 1314, 1258, 1204, 1192, 1147, 846. Mass
found: 585 (M+).
9-(4-((4-(Hexyloxy)phenyl)diazenyl)phenoxy)nonyl 3-(4-bromophenyl)acrylate
(28):
To a solution of triphenylphosphine (PPh3, 970 mg, 3.70 mmol) in dry CH2Cl2
(15 mL) was added dropwise bromotrichloromethane (BrCCl3, 720 mg, 3.63 mmol)
and the resulting solution was stirred at rt for 25 min, during which it turned yellow-
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brown. Thereafter, 3-(4-bromophenyl)acrylic acid (705 mg, 3.10 mmol) was added,
and the mixture was stirred at reflux temperature for 30 min. Then, 13 (608 mg, 1.38
mmol) was added, and the mixture was stirred at reflux for an additional 14h. The
cooled solution was submitted directly to column chromatography on silica gel
(CH2Cl2) to give (28) (653 mg, 77%) as a yellow solid.
δH (400 MHz, CDCl3) 0.89 (3H, t, CH3), 1.29-1.85 (24H, m, CH2), 3.83 (3H,
t, OCH3), 4.02 (4H, t, OCH2), 4.18 (2H, t, OCH2), 6.31 (1H, d, CH), 6.89 (2H, d, CH),
6.98 (4H, d, CH), 7.47 (2H, d, CH), 7.63 (1H, d, CH), 7.88 (4H, d, CH); δC (100.5
MHz, CDCl3) 14.1 (CH3), 22.6 (CH2), 26.0 (CH2), 28.7 (CH2), 29.1 (CH2), 29.2 (CH2),
29.2 (CH2), 29.3 (CH2) 29.4 (CH2), 31.8 (CH2), 55.4 (OCH2), 64.5 (OCH2), 68.3
(OCH2), 68.3 (OCH2), 114.3 (CH), 114.7 (CH), 115.7 (CH), 124.5 (CH), 127.2 (CH),
129.7 (CH), 144.2 (CH), 146.5 (CH), 161.3 (CH), 161.3 (CH), 167.5 (C=O), υ IR
(KBr, cm-1): 2935, 2856, 1703, 1633, 1602, 1580, 1514, 1497, 1474, 1246, 1176, 1149,
1021, 842. Mass found: 615 (M+).
(E)-9-(4-((E)-(4-(Heptyloxy)phenyl)diazenyl)phenoxy)nonyl 3-(3,4dimethoxyphenyl)acrylate (29):
To a solution of triphenylphosphine (PPh3, 970 mg, 3.70 mmol) in dry CH2Cl2
(15 mL) was added dropwise bromotrichloromethane (BrCCl3, 720 mg, 3.63 mmol)
and the resulting solution was stirred at rt for 25 min, during which it turned yellowbrown. Thereafter, 3-(3,4-dimethoxyphenyl) acrylic acid (640 mg, 3.08 mmol) was
added, and the mixture was stirred at reflux temperature for 30 min. Then, 13 (606 mg,
1.34 mmol) was added, and the mixture was stirred at reflux for an additional 14h. The
cooled solution was submitted directly to column chromatography on silica gel
(CH2Cl2) to give 29 (692 mg, 80%) as a yellow solid.
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δH (400 MHz, CDCl3) 0.89 (3H, t, CH3), 1.29-1.84 (22H, m, CH2), 3.91 (6H,
s, OCH3), 4.02 (4H, t, OCH2), 4.19 (2H, t, OCH2), 6.31 (1H, d, CH), 6.85 (1H, d, CH),
6.98 (4H, d, CH), 7.05 (1H, d, CH), 7.10 (1H, dd, CH), 7.62 (1H, d, CH), 7.87 (4H, d,
CH); δC (100.5 MHz, CDCl3) 14.1 (CH3), 22.6 (CH2), 26.0 (CH2), 28.8 (CH2), 29.0
(CH2), 29.1 (CH2), 29.2 (CH2) 29.2 (CH2), 29.3 (CH2), 29.4 (CH2), 31.8 (CH2), 55.9
(OCH3), 56.0 (OCH3), 64.6 (OCH2), 68.2 (OCH2), 68.3 (OCH2), 109.4 (CH), 110.9
(CH), 114.7 (CH), 115.9 (CH), 122.6 (CH), 124.4 (CH), 127.4 (CH), 144.5 (CH),
146.6 (CH), 149.1 (CH), 151.0 (CH), 161.1 (CH), 161.2 (CH), 161.3 (CH), 167.4
(C=O). υ IR (KBr, cm-1): 2921, 2853, 1703, 1630, 1600, 1579, 1514, 1500, 1473, 1254,
1137, 1023, 842. Mass found: 645 (M+).
(E)-11-(4-((E)-(4-(Hexyloxy)phenyl)diazenyl)phenoxy)undecyl 3-(4methoxyphenyl)acrylate (30):
To a solution of triphenylphosphine (PPh3, 770 mg, 2.94 mmol) in dry CH2Cl2
(15 mL) was added dropwise bromotrichloromethane (BrCCl3, 570 mg, 2.87 mmol)
and the resulting solution was stirred at rt for 25 min, during which it turned yellowbrown. Thereafter, 3-(4-methoxyphenyl)acrylic acid (440 mg, 2.47 mmol) was added,
and the mixture was stirred at reflux temperature for 30 min. Then, 17 (520 mg, 1.11
mmol) was added, and the mixture was stirred at reflux for an additional 14h. The
cooled solution was submitted directly to column chromatography on silica gel
(CH2Cl2) to give (30) (550 mg, 79%) as a yellow solid.
δH (400 MHz, CDCl3): 0.90 (3H, t, CH3), 1.31-1.82 (26H, m, CH2), 3.82 (3H,
s, OCH3), 4.02 (4H, t, OCH2), 4.19 (2H, t, OCH2), 6.31 (1H, d, CH), 6.89 (2H, d, CH),
6.98 (4H, d, CH), 7.47 (2H, d, CH), 7.63 (1H, d, CH), 7.86 (4H, d, CH); δC (100.5
MHz, CDCl3): 11.0 (CH3), 14.1 (CH2), 14.1 (CH2), 22.6 (CH2), 23.0 (CH2), 23.7

35
(CH2), 25.7 (CH2), 26.0 (CH2), 26.0 (CH2), 28.8 (CH2), 28.9 (CH2), 29.2 (CH2), 29.2
(CH2), 29.3 (CH2), 29.4 (CH2) 29.5 (CH2), 29.5 (CH2), 30.3 (CH2), 31.6 (CH2), 38.7
(CH2), 55.4 (OCH2), 64.6 (OCH2), 68.1 (OCH2), 68.3 (OCH2), 114.3 (CH), 114.6
(CH), 115.7 (CH), 124.3 (CH), 127.2 (CH), 128.8 (CH), 129.7 (CH), 130.9 (CH),
132.4 (CH), 144.2 (CH), 146.9 (CH), 161.1 (CH), 161.3 (CH), 167.4 (CH), 167.8
(C=O). υ IR (KBr, cm-1): 2935, 2856, 1703, 1633, 1602, 1580, 1514, 1497, 1474, 1246,
1176, 1149, 1021, 842. Mass found: 629 (M+).
(E)-11-(4-((E)-(4-propoxyphenyl)diazenyl)phenoxy)undecyl 3-(4methoxyphenyl)acrylate (31):
To a solution of triphenylphosphine (PPh3, 900 mg, 3.43 mmol) in dry CH2Cl2
(15 mL) was added dropwise bromotrichloromethane (BrCCl3, 670 mg, 3.38 mmol)
and the resulting solution was stirred at rt for 25 min, during which it turned yellowbrown. Thereafter, 3-(4-methoxyphenyl)acrylic acid (500 mg, 2.81 mmol) was added,
and the mixture was stirred at reflux temperature for 30 min. Then, 18 (454 mg, 1.07
mmol) was added, and the mixture was stirred at reflux for an additional 14h. The
cooled solution was submitted directly to column chromatography on silica gel
(CH2Cl2) to give 31 (435 mg, 69%) as a yellow solid.
δH (400 MHz, CDCl3) 0.99 (3H, t, CH3), 1.36-1.84 (22H, m, CH2), 3.82 (3H,
s, OCH3), 4.02 (4H, t, OCH2), 4.18 (2H, t, OCH2), 6.31 (1H, d, CH), 6.89 (2H, d, CH),
6.98 (4H, d, CH), 7.47 (2H, d, CH), 7.64 (1H, d, CH), 7.86 (4H, d, CH); δC (100.5
MHz, CDCl3) 13.8 (CH3), 19.2 (CH2), 25.9 (CH2), 25.9 (CH2), 28.7 (CH2), 29.1 (CH2),
29.2 (CH2), 29.3 (CH2), 29.4 (CH2), 31.2 (CH2), 55.4 (OCH2), 64.5 (OCH2), 68.0
(OCH2), 68.3 (OCH2), 114.3 (CH), 114.6 (CH), 115.7 (CH), 124.3 (CH), 127.2 (CH),
129.7 (CH), 144.2 (CH), 146.8 (CH), 161.1 (CH), 161.2 (CH), 161.3 (CH), 167.5
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(C=O). υ IR (KBr, cm-1): 2935.68, 2856.85, 1712.37, 1603.08, 1580.67, 1513.29,
1497.38, 1289.84, 1246.28, 1177.48, 1149.98, 1025.57, 983.77, 843.32. Mass found:
587 (M+).
(E)-11-(4-((E)-(4-Butoxyphenyl)diazenyl)phenoxy)undecyl 3-(3,4dimethoxyphenyl)acrylate (32):
To a solution of triphenylphosphine (PPh3, 900 mg, 3.43 mmol) in dry CH2Cl2
(15 mL) was added dropwise bromotrichloromethane (BrCCl3, 670 mg, 3.37 mmol)
and the resulting solution was stirred at rt for 25 min, during which it turned yellowbrown. Thereafter, 3-(3,4-dimethoxyphenyl)acrylic acid (530 mg, 2.55 mmol) was
added, and the mixture was stirred at reflux temperature for 30 min. Then, 19 (457 mg,
1.04 mmol) was added, and the mixture was stirred at reflux for an additional 14h. The
cooled solution was submitted directly to column chromatography on silica gel
(CH2Cl2) to give (32) (510 mg, 78%) as a yellow solid.
δH (400 MHz, CDCl3): 0.98 (3H, t, CH3), 1.31-1.83 (22H, m, CH2), 3.90 (6H,
s, OCH3), 4.02 (4H, t, OCH2), 4.18 (2H, t, OCH2), 6.31 (1H, d, CH), 6.85 (1H, d, CH),
6.98 (4H, d, CH), 7.05 (1H, dd, CH), 7.09 (1H, dd, CH), 7.62 (1H, d, CH), 7.86 (4H,
d, CH); δC (100.5 MHz, CDCl3): 13.8 (CH3), 19.2 (CH2), 25.9 (CH2), 26.0 (CH2), 28.7
(CH2), 29.1 (CH2), 29.2 (CH2) 29.3 (CH2), 29.4 (CH2), 29.5 (CH2), 29.5 (CH2), 31.2
(CH2), 55.8 (OCH3), 55.9 (OCH3), 64.6 (OCH2), 68.0 (OCH2), 68.3 (OCH2), 109.3
(CH), 109.4 (CH), 110.9 (CH), 114.6 (CH), 114.7 (CH), 115.9 (CH), 122.6 (CH),
124.4 (CH), 124.4 (CH), 124.5 (CH), 127.3 (CH), 144.4 (CH), 149.1 (CH), 150.9
(CH), 161.3 (CH), 167.3 (C=O); υ IR (KBr, cm-1): 2924, 2853, 1710, 1634, 1600,
1579, 1510, 1499, 1472, 1262, 1243, 1171, 1140, 1027, 847. Mass found: 631 (M+).
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(E)-11-(4-((E)-(4-butoxyphenyl)diazenyl)phenoxy)undecyl 3-(4(tetradecyloxy)phenyl)acrylate (33):
To a solution of triphenylphosphine (PPh3, 740 mg, 2.82 mmol) in dry CH2Cl2
(15 mL) was added dropwise bromotrichloromethane (BrCCl3, 550 mg, 2.77 mmol)
and the resulting solution was stirred at rt for 25 min, during which it turned yellowbrown. Thereafter, 3-(4-tetradecyloxyphenyl)acrylic acid (835 mg, 2.32 mmol) was
added, and the mixture was stirred at reflux temperature for 30 min. Then, (19) (400
mg, 0.91 mmol) was added, and the mixture was stirred at reflux for an additional 14h.
The cooled solution was submitted directly to column chromatography on silica gel
(CH2Cl2-hexane 4:1) to give 33 (485 mg, 68%) as a yellow solid.
δH (400 MHz, CDCl3): 0.88 (3H, t, CH3), 0.99 (3H, t, CH3), 1.25-1.84 (46H, m, CH2),
3.97 (2H, t, OCH2), 4.03 (4H, t, OCH2), 4.18 (2H, t, OCH2), 6.30 (1H, d, CH), 6.88
(2H, d, CH), 6.98 (4H, d, CH), 7.46 (2H, d, CH), 7.63 (1H, d, CH), 7.87 (4H, d, CH);
δC (100.5 MHz, CDCl3): 13.8 (CH3), 14.1 (CH3), 19.2 (CH3), 22.7 (CH2), 25.9 (CH2),
26.0 (CH2), 28.7 (CH2), 29.1 (CH2), 29.1 (CH2), 29.2 (CH2), 29.3 (CH2), 29.5 (CH2),
29.5 (CH2) 29.5 (CH2), 29.5 (CH2), 29.6 (CH2), 29.6 (CH2), 29.6 (CH2), 31.2 (CH2),
31.9 (CH2), 64.5 (OCH2), 67.9 (OCH2), 68.1 (OCH2), 68.3 (OCH2), 114.6 (CH), 114.6
(CH), 114.7 (CH), 115.4 (CH), 124.3 (CH), 126.8 (CH), 129.6 (CH), 144.3 (CH),
146.6 (CH), 160.9 (CH), 161.2 (CH), 167.5 (C=O); υ IR (KBr, cm-1): 2919, 2850,
1709, 1633, 1602, 1580, 1511, 1473, 1280, 1244, 1177, 1039, 984, 843. Mass found:
783 (M+).
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11-(4-((E)-(4-(Octyloxy)phenyl)diazenyl)phenoxy)undecyl cinnamate (34):
To a solution of triphenylphosphine (PPh3, 970 mg, 3.70 mmol) in dry CH2Cl2
(15 mL) was added dropwise bromotrichloromethane (BrCCl3, 720 mg, 3.63 mmol)
and the resulting solution was stirred at rt for 25 min, during which it turned yellowbrown. Thereafter, cinnamic acid (450 mg, 3.04 mmol) was added, and the mixture
was stirred at reflux temperature for 30 min. Then, 20 (610 mg, 1.23 mmol) was added,
and the mixture was stirred at reflux for an additional 14h. The cooled solution was
submitted directly to column chromatography on silica gel (CH2Cl2) to give 34 (655
mg, 85%) as a yellow solid.
δH (400 MHz, CDCl3): 0.89 (3H, t, CH3), 1.29-1.84 (30H, m, CH2), 4.02 (4H,
t, OCH2), 4.22 (2H, t, OCH2), 6.44 (1H, d, CH), 6.98 (4H, d, CH), 7.38 (3H, t, CH),
7.52 (2H, d, CH), 7.68 (1H, d, CH) 7.86 (4H, d, CH); δC (100.5 MHz, CDCl3): 14.1
(CH3), 22.6 (CH2), 25.9 (CH2), 26.0 (CH2), 28.7 (CH2), 29.1 (CH2), 29.2 (CH2), 29.2
(CH2) 29.2 (CH2), 29.3 (CH2), 29.3 (CH2), 29.5 (CH2), 29.5 (CH2), 31.8 (CH2), 64.7
(OCH2), 68.2 (OCH2), 68.3 (OCH2), 114.6 (CH), 118.2 (CH), 124.3 (CH), 128.0 (CH),
128.8 (CH), 130.2 (CH), 134.4 (CH), 144.5 (CH), 161.2 (CH), 167.1 (C=O); υ IR
(KBr, cm-1): 2918, 2849, 1712, 1602, 1579, 1498, 1473, 1309, 1244, 1146, 1107,
1040, 846. Mass found: 627 (M+).
(E)-11-(4-((E)-(4-(Octyloxy)phenyl)diazenyl)phenoxy)undecyl 3-(4methoxyphenyl)acrylate (35):
To a solution of triphenylphosphine (PPh3, 970 mg, 3.70 mmol) in dry CH2Cl2
(15 mL) was added dropwise bromotrichloromethane (BrCCl3, 720 mg, 3.63 mmol)
and the resulting solution was stirred at rt for 25 min, during which it turned yellow-

39
brown. Thereafter, 3-(4-methoxyphenyl)acrylic acid (530 mg, 3.00 mmol) was added,
and the mixture was stirred at reflux temperature for 30 min. Then, 20 (600 mg, 1.21
mmol) was added, and the mixture was stirred at reflux for an additional 14h. The
cooled solution was submitted directly to column chromatography on silica gel
(CH2Cl2) to give 35 (625 mg, 78.5%) as a yellow solid.
δH (400 MHz, CDCl3): 0.88 (3H, t, CH3), 1.24-1.84 (24H, m, CH2), 3.83 (3H,
s, OCH3), 4.02 (4H, t, OCH2), 4.18 (2H, t, OCH2), 6.31 (1H, d, CH), 6.89 (2H, d, CH),
6.98 (4H, d, CH), 7.47 (2H, d, CH), 7.63 (1H, d, CH), 7.86 (4H, d, CH); δC (100.5
MHz, CDCl3): 14.1 (CH3), 22.6 (CH2), 25.9 (CH2), 26.0 (CH2), 28.7 (CH2), 29.2
(CH2), 29.2 (CH2), 29.2 (CH2), 29.2 (CH2) 29.3 (CH2), 29.3 (CH2), 29.4 (CH2), 29.5
(CH2), 31.8 (CH2), 55.3 (OCH2), 68.2 (OCH2), 68.2 (OCH2), 68.3 (OCH2), 114.2
(CH), 114.6 (CH), 115.7 (CH), 124.3 (CH), 127.1 (CH), 129.6 (CH), 144.2 (CH),
146.7 (CH), 161.1 (CH), 161.2 (CH), 167.4 (C=O); υ IR (KBr, cm-1): 2029, 2851,
1702, 1632, 1602, 1580, 1514, 1496, 1473, 1289, 1243, 117, 1027, 842. Mass found:
657 (M+).
(E)-11-(4-((E)-(4-(Octyloxy)phenyl)diazenyl)phenoxy)undecyl 3-(3,4dimethoxyphenyl)acrylate (36):
To a solution of triphenylphosphine (PPh3, 970 mg, 3.70 mmol) in dry CH2Cl2
(15 mL) was added dropwise bromotrichloromethane (BrCCl3, 720 mg, 3.63 mmol)
and the resulting solution was stirred at rt for 25 min, during which it turned yellowbrown. Thereafter, 3-(3,4-dimethoxyphenyl)acrylic acid (630 mg, 3.03 mmol) was
added, and the mixture was stirred at reflux temperature for 30 min. Then, 20 (610 mg,
1.23 mmol) was added, and the mixture was stirred at reflux for an additional 14h. The
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cooled solution was submitted directly to column chromatography on silica gel
(CH2Cl2) to give 36 (660 mg, 78%) as a yellow solid.
δH (400 MHz, CDCl3): 0.89 (3H, t, CH3), 1.29-1.84 (22H, m, CH2), 3.91 (6H,
s, OCH3), 4.02 (4H, t, OCH2), 4.19 (2H, t, OCH2), 6.31 (1H, d, CH), 6.85 (1H, d, CH),
6.98 (4H, d, CH), 7.05 (1H, dd, CH), 7.09 (1H, dd, CH), 7.62 (1H, d, CH), 7.86 (4H,
d, CH); δC (100.5 MHz, CDCl3): 10.5 (CH3), 22.5 (CH2), 25.9 (CH2), 26.0 (CH2), 28.7
(CH2), 29.2 (CH2) 29.2 (CH2), 29.3 (CH2), 29.5 (CH2), 29.5 (CH2), 55.8 (OCH3), 55.9
(OCH3), 64.6 (OCH2), 68.2 (OCH2), 69.7 (OCH2), 109.3 (CH), 110.9 (CH), 114.6
(CH), 115.9 (CH), 122.6 (CH), 124.3 (CH), 127.3 (CH), 144.4 (CH), 146.7 (CH),
149.1 (CH), 150.9 (CH), 161.1 (CH), 161.1 (CH), 167.3 (C=O); υ IR (KBr, cm-1):
2918, 2848, 1698, 1601, 1580, 1515, 1499, 1472, 1268, 1247, 1140, 1023, 847. Mass
found: 687 (M+).
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2.2.3 Third path-way

(12&17)

(37&40)

(38&41)

(39&42)

Scheme 2: synthesis of steroidal azo ethers

The synthetic route shown in scheme 2 will be used In order to synthesis the
steroidal azo ethers.
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(E)-1-(4-((9-Chlorononyl)oxy)phenyl)-2-(4-(hexyloxy)phenyl)diazene (37):
To a solution of triphenylphosphine (PPh3, 2.7 g, 10.4 mmol) in dry CH2Cl2
(20 mL) was added dropwise tetrachloromethane (CCl4, 1.6 g, 11.1 mmol), and the
resulting solution was stirred at rt for 25 min, during which it turned yellow-brown.
Thereafter, 12 (3.3 g, 7.4 mmol) was added, and the mixture was stirred at room
temperature for 14 h. The solution was submitted directly to column chromatography
on silica gel (CH2Cl2) to give (1.3 g, 82%) as a yellow solid.
δH (400 MHz, CDCl3): 0.92 (3H, t, CH3), 1.35-1.84 (22H, m, CH2), 3.53 (2H,
t, OCH2), 4.03 (4H, t, OCH2), 6.98 (4H, d, CH), 7.86 (4H, d, CH); δC (100.5 MHz,
CDCl3): 14.0 (CH3), 22.5 (CH2), 25.6 (CH2), 25.9 (CH2), 26.8 (CH2), 28.8 (CH2), 29.1
(CH2), 29.2 (CH2) 29.3 (CH2), 31.5 (CH2), 32.6 (CH2), 45.1 (CH2), 68.2 (OCH2), 68.3
(OCH2), 114.6 (CH), 124.2 (CH), 146.9 (CH), 146.9 (CH), 161.1 (CH), 161.1 (CH);
IR υ (KBr, cm-1): 2935, 2852, 1602, 1579, 1499, 1472, 1316, 1244, 1143, 1107, 1017,
842, 723, 556.
(E)-1-(4-(Hexyloxy)phenyl)-2-(4-((9-iodononyl)oxy)phenyl)diazene (38):
A mixture of 37 (2.6 g, 5.6 mmol) and sodium iodide (NaI, 1.7 g, 11.3 mmol)
was dissolved in dry acetone (20 mL). The mixture was stirred at reflux temperature
for 48 h. Thereafter, an excess of water was added to the resulting solution dropwise
and then a yellow precipitate was formed. The precipitate was filtered off and dried to
give 38 as a solid (1.9 g, 67%).
δH (400 MHz, CDCl3): 0.92 (3H, t, CH3), 1.34-1.86 (22H, m, CH2), 3.19 (2H,
t, OCH2), 4.02 (4H, t, OCH2), 6.98 (4H, d, CH), 7.86 (4H, d, CH); δC (100.5 MHz,
CDCl3): 14.0 (CH3), 22.6 (CH2), 25.7 (CH2), 25.9 (CH2), 26.8 (CH2), 28.4 (CH2), 28.8
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(CH2), 29.1 (CH2), 29.2 (CH2), 29.3 (CH2) 29.3 (CH2), 30.4 (CH2), 31.5 (CH2), 32.6
(CH2), 45.1 (CH2), 68.2 (OCH2), 68.3 (OCH2), 114.6 (CH), 124.2 (CH), 146.8 (CH),
146.9 (CH), 161.1 (CH), 161.1 (CH); IR υ (KBr, cm-1): 2930, 2851, 1600, 1579, 1450,
1322, 1243, 1145, 1016, 844.
(E)-1-(4-((9-((10,13-Dimethyl-17-(6-methylheptan-2-yl)-2,3,4,7,8,9,10,11,12
,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl)oxy)nonyl)-oxy)
phenyl)-2-(4-(hexyloxy)phenyl)diazene (39):
Sodium hydride (NaH, 220 mg, 9.1 mmol) was added to dry THF (9 mL) and
the resulting suspension was stirred for 10 min. Then, cholesterol (530 mg, 1.3 mmol)
was added slowly to the solution. After 10 min, 38 (500 mg, 0.91 mmol) was added to
the solution, and the reaction mixture was stirred for 48 h at 55 °C. Thereafter, water
(20 mL) was added dropwise and the mixture was extracted with chloroform (3 X 25
mL). The organic phase was dried over anhydrous MgSO4 and concentrated in vacuo.
The residue was submitted to column chromatography on silica gel (CH2Cl2 1:4
hexane) to give 39 (97 mg, 13%) as a yellow solid.
δH (400 MHz, CDCl3): 0.66 (3H, s, CH3), 0.82-2.37 (63H, m), 3.12 (1H, m,
CH), 3.44 (2H, t, OCH2), 4.02 (4H, t, OCH2), 5.34 (1H, m, CH), 6.98 (4H, d, CH),
7.85 (4H, d, CH); δC (100.5 MHz, CDCl3): 11.8 (CH3), 14.0 (CH3), 18.7 (CH3), 19.3
(CH3), 21.0 (CH2), 22.5 (CH2), 22.6 (CH3), 22.8 (CH3), 23.8 (CH2), 24.2 (CH2), 25.7
(CH2), 25.9 (CH2), 26.1 (CH2), 28.0 (CH), 28.2 (CH2), 28.4 (CH2), 29.1 (CH2), 29.2
(CH2), 29.3 (CH2), 29.4 (CH2), 29.7 (CH2), 30.1 (CH2), 31.5 (CH2), 31.8 (CH), 31.9
(CH2), 35.7 (CH), 36.1 (CH2), 36.8 (C), 37.2 (CH2), 39.2 (CH2), 39.5 (CH2), 39.7
(CH2), 42.2 (C), 50.1 (CH), 56.1 (CH), 56.7 (CH2), 68.1 (CH2), 68.2 (CH2), 68.2
(CH2), 78.9 (CH), 114.6 (CH), 121.3 (CH), 124.2 (CH), 141.1 (C), 146.8 (C), 161.1
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(C); IR υ (KBr, cm-1): 2931, 2852, 1600, 1579, 1499, 1473, 1250, 1144, 1101, 841.
Mass Found: 810 (M+).
(E)-1-(4-((11-Chloroundecyl)oxy)phenyl)-2-(4-(hexyloxy)phenyl)diazene (40):
To a solution of triphenylphosphine (PPh3, 1.34 g, 5.1 mmol) in dry CH2Cl2
(10 mL) was added dropwise tetrachloromethane (CCl4, 0.8 g, 5.4 mmol) and the
resulting solution was stirred at room temperature for 25 min, during which it turned
yellow-brown. Thereafter, 17 (1.7 g, 3.6 mmol) was added, and the mixture was stirred
at room temperature for 14 h. The solution was submitted directly to column
chromatography on silica gel (CH2Cl2) to give 40 (1.2 g, 72%) as a yellow solid.
δH (400 MHz, CDCl3): 0.91 (3H, t, CH3), 1.30-1.84 (26H, m, CH2), 3.53 (2H,
t, OCH2), 4.02 (4H, t, OCH2), 6.98 (4H, d, CH), 7.86 (4H, d, CH); δC (100.5 MHz,
CDCl3): 14.06 (CH3), 22.61 (CH2), 25.70 (CH2), 25.98 (CH2), 26.01 (CH2), 26.85
(CH2), 26.88 (CH2), 28.88 (CH2), 29.17 (CH2), 29.27 (CH2) 29.37 (CH2), 29.44 (CH2),
32.61 (CH2), 45.20 (CH2), 68.23 (OCH2), 68.29 (OCH2), 114.61 (CH), 124.27 (CH),
146.86 (CH), 146.88 (CH), 161.09 (CH), 161.13 (CH); IR υ (KBr, cm-1): 2935, 2854,
1602, 1581, 1498, 1474, 1316, 1247, 1150, 1108, 1027, 843.
(E)-1-(4-(Hexyloxy)phenyl)-2-(4-((11-iodoundecyl)oxy)phenyl)diazene (41):
A mixture of 40 (0.4 g, 0.86 mmol) and sodium iodide (0.98 g, 6.6 mmol) was
dissolved in 8 ml dry acetone. The mixture was stirred at reflux temperature for 48 h.
Thereafter, an excess of water was added to the resulting solution dropwise, and then
a yellow precipitate was formed. The precipitate was filtered off and dried to give 41
as a yellow solid (0.3 g, 69%).
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δH (400 MHz, CDCl3): 0.91 (3H, t, CH3), 1.29-1.84 (26H, m, CH2), 3.19 (2H,
t, OCH2), 4.03 (4H, t, OCH2), 6.98 (4H, d, CH), 7.85 (4H, d, CH); δC (100.5 MHz,
CDCl3): 14.0 (CH3), 22.6 (CH2), 25.7 (CH2), 25.9 (CH2), 26.0 (CH2), 26.8 (CH2), 28.4
(CH2), 29.1 (CH2), 29.2 (CH2) 29.3 (CH2), 30.4 (CH2), 31.5 (CH2), 33.5 (CH2), 68.2
(OCH2), 68.3 (OCH2), 114.6 (CH), 124.2 (CH), 146.8 (CH), 146.8 (CH), 161.0 (CH),
161.1 (CH); IR υ (KBr, cm-1): 2935, 2851, 1602, 1580, 1500, 1471, 1246, 1147, 1016,
844.
(E)-1-(4-((11-((10,13-Dimethyl-17-(6-methylheptan-2-yl)-2,3,4,7,8,9,10,11,12
,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl)oxy)undecyl)
oxy)phenyl)-2-(4-(hexyloxy)phenyl)diazene (42):
Sodium hydride (NaH, 173 mg, 7.2 mmol) was added to dry THF (5 mL), and
the resulting suspension was stirred for 10 min at rt. Then, cholesterol (464 mg, 1.2
mmol) was added slowly to the solution. After 10 min, 41 (280 mg, 0.483 mmol) was
added to the resulting solution, and the reaction mixture was stirred for 48 h at 55 °C.
Thereafter, water (20 mL) was added dropwise and the mixture was extracted with
chloroform (3 X 25 mL). The organic phase was dried over anhydrous MgSO4 and
concentrated in vacuo. The residue was submitted directly to column chromatography
on silica gel (CH2Cl2 1:4 C6H14) to give 42 (60 mg, 16%) as a yellow solid.
δH (400 MHz, CDCl3) 0.66 (3H, s, CH3), 0.85-2.37 (67H, m), 3.11 (1H, m,
CH), 3.44 (2H, t, OCH2), 4.02 (4H, t, OCH2), 5.34 (1H, m, CH), 6.98 (4H, d, CH),
7.86 (4H, d, CH); δC (100 MHz, CDCl3): 11.8 (CH3), 14.0 (CH3), 18.7 (CH3), 19.3
(CH3), 21.0 (CH2), 22.5 (CH2), 22.6 (CH3), 22.8 (CH3), 23.8 (CH2), 24.2 (CH2), 25.7
(CH2), 25.9 (CH2), 26.0 (CH2), 26.1 (CH2), 28.0 (CH), 28.2 (CH2), 28.4 (CH2), 29.1
(CH2), 29.2 (CH2), 29.3 (CH2), 29.4 (CH2), 29.5 (CH2), 30.1 (CH2), 31.5 (CH2), 31.8
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(CH), 31.9 (CH2), 35.7 (CH2), 36.1 (CH2), 36.8 (C), 37.2 (CH2), 39.2 (CH2), 39.5
(CH2), 39.7 (CH2), 42.2 (C), 50.1 (CH), 56.1 (CH), 56.7 (CH2), 68.1 (CH2), 68.2
(CH2), 68.2 (CH2), 78.9 (CH), 114.6 (CH), 121.3 (CH), 124.2 (CH), 141.1 (C), 146.8
(C), 161.1 (C); IR (KBr, cm-1): 2932, 2851, 1601, 1579, 1499, 1473, 1249, 1144, 1100,
1029, 840. Mass Found: 838 (M+).
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Chapter 3: Results and Discussion
3.1 Synthesis of the target compounds
The reactions start from commercially available 4-nitrophenol (8), which is
subjected to a Williamson ether synthesis with various commercially available ωbromoalkan-1-ols. With the relatively acidic phenol system, K2CO3 can be used as a
base. Some of the products could be gained by simple extraction, some of the products
needed to be purified by column chromatography on silica gel. Next, the nitro group
in (9 & 14) was to be reduced. There are various ways on how to reduce nitrobenzenes
to anilines such as with low valent metals in acidic medium such as with zinc or tin(II).
(Faul & Thiel, 2005) Further, a reduction with samarium is possible. (Basu, Becker, &
Banik, 2000) Efficient, however, is the hydrogenation of nitrobenzenes over metal
catalysts as little solid wastes are created as side products. Typical metal catalysts for
this reaction are Raney Nickel, (Allen & VanAllan, 2003) finely divided nickel on
solid, (Mazaheri & Kalbasi, 2015) also in form of Urushibara nickel, as well as
platinum oxide PtO2. Furthermore, palladium on carbon is a popular hydrogenation
catalyst. The hydrogenation of compounds (9 & 14) over 10w% Pd/C in THF using a
hydrogen balloon was successful and the anilines (10 & 15) were produced almost
quantitatively, where there was no need for extensive purification. Because of safety
concerns, later NaBH4–acetic acid was used as an internal hydrogen source. These
reactions, however, were very slow to complete. No water was added to the medium
so that every mole NaBH4 only produced ½ mole H2, the other product being borane
(BH3), which is in equilibrium with diborane (B2H6). It is known that decaborane
(B10H14) in acetic acid also hydrogenates nitrobenzenes to anilines, so perhaps in the
present case the scale of the reaction was a hindrance with the reaction conditions used.
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It is known that the addition of H2O to B2H6 produces hydrogen, also, but the addition
of H2O was not tried. Instead, the direct hydrogenation of the nitrobenzenes to anilines
was continued. Next, the obtained anilines were subjected to a diazotization (NaNO2,
HCl) in the presence of phenol to give diazobenzenes (11 & 16). This reaction proved
to be tricky and the reaction yields were variable. The diazobenzenes (11 & 16) were
alkylated at the phenol OH using K2CO3 as base. The base is not strong enough to also
deprotonate the alcohol function in (11 & 16), so that the alkylation proceeds at the
phenolic OH, only, although the reaction temperature needed is quite high (120 °C).
For the preparation of azo-cinnamates (21-36), the final step is an esterification
reaction. Normally, this would proceed via an acyl halide, ie., via a cinnamoyl halide.
We had only little thionyl chloride left, which we used to prepare cinnamoyl chloride
(Figures 16&17). (Becker, Berger, & Domschke, 1996) No other chlorinating or
brominating agent was available (PBr3, PCl3, PCl5, POCl3 or SO2Cl2). Also, it was
evident when preparing cinnamoyl chloride that the preparation and especially the
distillation of the prepared acid halides would be difficult. So, we decided to generate
acyl halides in situ, via Appel reaction. Here, we used triphenylphosphine–
bromotrichloromethane

(PPh3-BrCCl3)

instead

of

triphenylphosphine

–

tetrachlorocarbon (PPh3-CCl4) or triphenylphosphine - tetrabromomethane (PPh3CBr4) to produce the acid halide which is most likely a mixture of chloride and
bromide. The reasons behind this has to do with the fact that tetrachlorocarbon is an
ozone depletory and therefore should not be used at an academic institution.
Bromotrichlorocarbon is significantly more polar and so does not present such a grave
environmental hazard.
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(44)

(43

Figure 16: Preparation of the cinnamoyl
chloride (44) started from (43)
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Figure 17: 13C of both cinnamic acid & cinnamoyl chloride, respectively
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There are many common ways that can be used to prepare cinnamic acid
derivatives such as Heck reaction (Carmichael, Earle, Holbrey, McCormac, & Seddon,
1999), Perkin reaction (John, n.d.) and Knoevenagel reactions (Pal & Sarkar, 2014).
Nevertheless, the Wittig reaction is used extensively to prepare cinnamic acid
derivatives. In this work, the different cinnamic acids that have been used to synthesize
our azo-cinnamate compounds were obtained through previous work reacting
different, substituted benzaldehydes with ethoxymethylidenetriphenylphosphorane
(1.3eq) at 70 °C in 10w% aq. NaOH solution to form sodium cinnamates. After that,
upon neutralization of the aqueous solutions with 15w% aq. HCl, the cinnamic acids
were obtained by filtration and air-drying of the solids (Figure 18) (Thiemann et al.,
2016).

Figure 18: General way of substituted cinnamic acid
preparation
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The preparation of azobenzene-alkyl-cholesterol was a little tricky, also. The
coupling reaction of the alkoxy-azobenzene with the cholesterol needed two
intermediate steps for the conversion of the hydroxy group in the alkoxy-azobenzene
to a halo group (first Cl, then I by Finkelstein reaction). This way was more efficient
than the conversion of the hydroxy group to a halo group (Cl then I) in the cholesterol.
3-Chloro-3-deoxycholesterol was prepared by Appel reaction without problem (Figure
19a). However, the Finkelstein reaction to convert it to the iodo-derivative did not
work (Figure 19b).

(a
47

48

(b)
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Figure 19: Synthesis of: a) cholesteryl chloride, b) cholesteryl iodide
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Also,

the

direct

coupling

of

the

3-chloro-3-deoxycholsterol

with

the

hydroxyalkoxybenzene did not proceed well (Figure 20).

Figure 20: The reaction of the cholesterol chloride with the
alkoxyazobenzene does not succeed

Nevertheless, it was possible to link the cholesterol as the alcohol component
to the iodo derivative (38&41) by Williamson-type synthesis with NaH as base in dry
THF to get the target compounds (39&42). Here, alkenes (45) & (46) was found as a
by-product (Figure 21), suggesting a competing E2-elimination pathway. The byproduct could be separated easily using column chromatography. The 1H and

13

NMR of the alkene is shown in Figure 22.

(39) & (42)

(38) & (41)

(45) & (46)

Figure 21: Alkene (44) & (45) as side-product in the coupling of the alkoxyazobenzene with the cholesterol {44 when (n=11, m=5)\ 45 when(n=9, m=5)}
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Figure 22: 1H NMR & 13C NMR of compound (44)
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3.2 Photochemical behavior of azobenzene cinnamates
UV spectroscopy is an important field to identify electronic transitions in
compounds, especially in organic compounds which have a chromophore in their
structures. Also it is a powerful tool to obtain information on the photo-behavior of the
materials. In this chapter, I will discuss the UV spectra of our synthesized compounds.
Also, I will discuss the photoisomerization experiments that were carried out.
Table 1 shows the absorption bands of the synthesized azocinnamates, showing
an absorption band for the trans-cinnamate moiety (λmax1 and λmax2), the trans form of
the azobenzene moiety (λmax3) and the cis form of the azobenzene moiety. The results
obtained show that the λmax for the -C=C- depends strongly on the substitution pattern
of the cinnamate unit. This again determines how well the bands of the -C=C- moiety
and the –N=N- moiety are separated from each other.

Table 1: λmax of the azo-cinnamates
Compound
name

λmax1 λmax2 λmax3 Compound λmax1 λmax2 λmax3
(nm)

(nm)

name

(nm)

(nm)

(nm)

21

275

360

29

295

325

360

22

310

360

30

310

360

325

360

31

310

360

24

312

360

32

325

360

25

286

360

33

312

360

26

259

360

34

275

360

27

275

360

35

310

360

28

310

360

36

325

360

23

(nm)

295

295

295
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As mentioned above, the cinnamate chromophore has a UV absorption at
different wavelengths than the azobenzene chromophore. The different substitution
pattern on the cinnamate moiety changes the position of λmax and sometimes shifts the
absorption band towards higher wavelength, causing overlap with the azobenzene
absorption band. This shift, in some cases, means that we can no longer selectively
irradiate the azo moiety without affecting the double bond of the cinnamate. This
means that upon irradiation, (E-Z) isomerization of the double bond would also
happen. A theoretical calculation has been done to show the effect of the substitution
patterns on the absorption band of the cinnamate moiety. Those calculations were done
using Gaussian 03W program and the compounds were modeled in the gas phase.
The geometry of the compounds was optimized using B3LYP hybrid
functional and 6-31G(d) basis set. The estimated UV-absorption bands showed a
closely similar pattern to what we have observed practically. The Figures 23-25 show
the absorption bands of cinnamates with different substitution patterns. The reason
behind this differences in the number of bands is the symmetry of the cinnamate
moiety. The compounds 49, 50, 51 have maximum absorption at different wavelength
in the gas phase (Compd. 49: max= 277 nm [pract. 275 nm]), (Compd. 50: max= 300
nm [pract. 310 nm]) and (Compd. 51: max1= 282 nm [pract. 295 nm], max2= 329 nm
[pract. 325 nm]) respectively. Previous work found the maximum absorption of
compound 50 experimentally in two further solvents, cyclohexane and methanol at
max= 290 nm, and 308 nm, respectively, indicating some solvent dependency in the
absorption (Peperstraete et al., 2016).
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Figure 23: UV-absorption band of the Methyl
Cinnamate (49)

Figure 24: UV-absorption band of the (E)-methyl 3(4-methoxyphenyl)acrylate (50)
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Figure 25: UV-absorption band of (E)-methyl 3-(3,4dimethoxyphenyl)acrylate (51)
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3.2.1 Photoisomerization experiment
The main idea was to trigger only the azo group in the synthesized azocinnamates while leaving the (trans-)-C=C- of the cinnamate unit untouched by
irradiating the molecules at λ= 350 nm. In addition, the thermal isomerization
backward from the cis-azo isomer to the trans-azo isomer was also to be part of the
investigation. In the last decades, similar experiments have been done with
photoswitching materials. For the azobenzenes, there are two proposed mechanisms
for the photoisomerization of the azo functionality, which are an inversion (n-π*) and
a rotational (π-π*) mechanism as shown in Figure 26.

Figure 26: Established photoisomerization mechanisms of the azobenzene moiety
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In the rotation mechanism, the cis-trans isomerization is going through a πbond rupture so that the transition state no longer has a planar structure and C-N.-N.C exhibits no linearity (Figure 27), while the inversion mechanism proceeds through
a transition state with linear hybridization in which the double bond is retained. In this
case, the intermediate has a semi-linear geometry as shown in Figure 26. The energy
needed for the rotation mechanism to proceed is higher than for the inversion (Figure
21) (Tamai & Miyasaka, 2000; Yang et al., 2013).

“Rotation mechanism”

“Inversion mechanism”

Figure 27: Mechanism of both inversion and rotational isomerization
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3.2.2 Photoisomerization followed by UV spectroscopy
Azobenzene is the most common example of a photoswitching compound. The
UV spectrum of the azobenzene shows the n-π* transition peak in the visible region
with a low intensity peak as compared to the π-π* peak. The π-π* peak appears in the
ultraviolet region. The substitution pattern in the 4 and 4’ positions of the azobenzene
affects the optical properties as well as the absorption bands. Adding to the structure
another chromophore such as a cinnamate unit might also affect the absorption band
of the whole compound.
The maximum absorption of the -C=C-(CO)Ph band of the cinnamate can be
shifted to shorter wavelengths with a different intensity depending on the substitution
patterns. Photoisomerization experiments were performed for our synthesized
compounds, which have different substitution patterns on the cinnamate with different
chain lengths connecting cinnamate and azobenzene moiety. In the photoisomerization
experiments, the sample concentrations were the same for all compounds (1.0*10-5
mol/L) in order to have an idea about the isomerization time. The experiments were
followed using UV spectroscopy and 1H NMR spectroscopy. The Figures below
(Figures 28, 29, 30, 31, 32) show the change of the UV spectra of the compounds
during trans-cis isomerization (Figures a) and thermal cis-trans conversion (Figures
b).
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For all Figures 28-32, the Y-axis represents the absorbance while the X-axis
represent the wavelength in nm. During the irradiation, the compound 26 took the
shortest time (30 s) to reach the maximum conversion from trans to cis form
(photostationary phase), while compounds 33, 34, and 35 took 35 s. The slowest
compound is 32, taking 40 s to reach the photostationary phase.
The results proved that the isomerization time depends on the terminal
substitution and different carbon chains linked between the moieties. For all
compounds (26, 32, 33, 34, 35), with increasing the radiation time, the absorption peak
around 358 nm starts to decrease (trans form) while the peak around 450 nm increases
(cis form). Those changes are representing the trans to cis isomerization of the azo
group (figures 28a-32a). There are small changes with the -C=C- bands, but those are
not indicating a E-Z isomerization. Those changes are due to a temperature change
(mostly due to the heat dissipation from the instrument), different concentrations of
oxygen in the samples and an instable baseline of long measurement times. NMR data
proved that the cinnamate E-Z isomerization did not happen and this will be discussed
in the next subchapter. Figures b exhibiting the conversion from cis to trans form
thermally show that there is a difference in the kinetics of the cis to trans isomerization
of the azo cinnmates, again depending on the substitution pattern of the cinnamates.
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a

b

Figure 28: UV spectra of: a) during irradiation 350 nm, b) backward
thermally of compound 26
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a

b

Figure 29: UV spectra of: a) during irradiation 350 nm, b)
backward thermally of compound 32
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a

b

Figure 30: UV spectra of: a) during irradiation 350 nm,
b) backward thermally of compound 33
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a

b

Figure 31: UV spectra of: a) during irradiation 350 nm,
b) backward thermally of compound 34
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a

b

Figure 32: UV spectra of: a) during irradiation 350 nm,
b) backward thermally of compound 35
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3.2.3 Photoisomerization followed by NMR spectroscopy
The photoisomerization experiments of compounds 26, 33, 34 and 35 were
followed using 1H NMR spectroscopy. For compound 26, the NMR peaks which are
related to the cis form start to show after 7 min of radiation. With increasing irradiation
time, the trans-cis isomerization keeps increasing until 15 min have passed, as shown
in the Figure 33. Also, from the NMR data we can conclude that the E-Z isomerization
of the -C=C- of the cinnemate moiety is not happening because the protons of the Cis
form do not appear at δH around 5.9 ppm. (Fukuda et al., 2016)
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The 1H NMR spectra in the (Figure 34) below shows the thermal isomerization
of the compound 26. As expected, the spectra show that the compound starts to
isomerize back thermally to the trans form with increasing time in absence of
irradiation. It seems that even after 25 hrs, the conversion is not totally complete.
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The Figures 35 and 36 below shows the trans-cis isomerization of 34 during
photoirradiation. It appears that compound 34 exhibits the same kinetics as compound
26 for both processes, the photochemical trans-cis isomerization and the thermal cistrans isomerization.
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Figure 35: 1H NMR of compound 34 during irradiation
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Compound 35 exhibits similar behavior as compared to the compounds 26 and
34 during the photo-irradiation process, but E-Z isomerization of -C=C- of the
cinnamate moiety also occurred on a very small scale. The reason behind this
isomerization is that the absorption band of the -C=C- (λmax 312 nm) is much closer to
the irradiation region as compared with compounds 26 and 35 ((λmax 259 nm and (λmax
280 nm, respectively). This convergence might be effected further by the irradiation
with the time of irradiation. It seems that the E-Z isomerization of the cinnamate
moiety does not occur immediately as shown in the Figure 37. After 5 min irradiation
there is no peak evident for the cis form, while after 25 min small peaks started to
appear. From the integration, the ratio between the Z to E forms are 10:90.
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As the E-Z isomerization of the -C=C- moiety is not a thermally reversible
process and, as we expected, the peaks related to the cis form do not decrease with
time (in absence of irradiation), while the cis-trans isomerization of the azo group is
thermally a reversible process, and so the intensity of the peaks related to the cis form
of the azo group of compound 35 started to decrease with time in absence of irradiation
(Figure 38).
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The 1H NMR spectra in the (Figure 39) below, proves that compound 33
exhibits a behavior similar to compound 35, because the absorption band of the -C=Cof the cinnamate unit of compound 33 is with 312 nm is similarly close to the λmax of
the azo group. The ratio between the Z to E forms after 20 min. photoirradiation in this
case is 20:80.
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3.3 X-ray crystal structure
3.3.1 X-ray crystal structure of azocinnamate 29
A single crystal of compound 29 was grown by slow evaporation a solution of
the compound in methanol & dichloromethane (DCM) (1:3) at room temperature. The
crystals were measured using a Bruker APEX DUO diffractometer with CCD area
detector and monochromatic MoKα radiation (λ= 0.71069) (NYU-AD, Prof. Panče
Naumov). Figure 40 shows the shape of the molecule, which exhibits for the most part
a linear and rod like structure. At the tail-end, however, there is a kink. It can be seen
that this kink is due to the interactions that holds the molecules together. In fact, the
stacking of the molecules in the crystal is quite interesting. Interaction between two
stacked molecules is mostly at both ends of the molecules by C-H…pi interaction.

Figure 40: Structure with atomic labels & phenyl rings labels (R1-3)
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The Figure 41, show how the molecules stack over each other within layers.
As shown, specific short contacts between molecules are only through C-H…pi
interactions. It would be expected that the interactions is weak which can give the
molecules more possibility to move against each other when given the energy through
heating. On the other hand, the packing of the relatively long rod-like molecules would
indicate an initial movement of the molecules in the direction of their long axis, which
may mean that a liquid crystalline nematic state, even though perhaps only over a short
temperature range, could be expected.

Figure 41: The C-H…pi interaction showed by blue cyan
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3.3.2 X-ray crystal structure of 9-(4-Nitrophenoxy)nonan-1-ol (9)
Figure 42 below shows the crystal structure of one of the intermediates.
Molecule 9 exhibits for the most part a linear and rod like structure. Single crystals
from dichloromethane – methanol (3:1).

Figure 42: ORTEP drawing of the single crystal structure of compound 9
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3.4 Thermal analyses
One of the instruments used to identify phase transitions is the differential
scanning calorimeter (DSC). The Figures 43-48 below show the DSC measurements
for azo-cinnamates 24-27 and 35, 36. For all compounds, two cycles were run. The
lower trace is the heating phase, the upper trace shows the cooling phase. All
compounds show more than one transition in the cooling phase except for anthrylsubstituted compound 26 (Figure 44). It would be not expected that the anthryl
compound would show a mesophase. Later, this was confirmed, when compound 26
was viewed under a polarization microscope. Some of the compounds show a
transition in addition to the transition from the solid (crystalline) phase to the isotropic
phase. Some of these transitions shown in the heating cycle (eg., figure 48) would be
expected to be crystal to crystal transformations as was shown for compound 24 under
the polarization microscope. In the cooling cycle, many compounds exhibit a transition
before the crystallization sets in. In the DSC of compound 24, this transition is at
around 111 oC. These transitions are from the isotropic state to the nematic phase. The
series of compounds that have a 3,4-dimethoxycinnamate substituent show thermally
a relatively strong signal in the cooling cycle; these substances such as 36, as viewed
under the optical polarization microscope show both a nematic and a smectic A phase
(albeit for 36 with a narrow temperature of 3 oC [74-71 oC]) upon rapid cooling.
Contact of 24 with cholesteryl esters led to the induction of a cholesteric phase (Figure
53).
Steroidal azo ether 42 shows a reentrant chiral nematic (cholesteric) phase at
around 120 oC. A contact with PCH-7 at 122 oC showed a chiral nematic phase, where
the helical pitch decreases with increasing concentration of 42.
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Figure 43: DSC thermogram of compound 25

Figure 44: DSC thermogram of compound 26
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Figure 45: DSC thermogram of compound 27

Figure 46: DSC thermogram of compound 35
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Figure 47: DSC thermogram of compound 36

Figure 48: DSC thermogram of the compound 24
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3.4.1 Thermotropic behavior of compound 24
Upon heating, the substance was found to melt at 114-115 °C. Cooling from
130 °C gave needles at 115.5 °C. Rapid cooling showed a nematic phase at 112.7 °C.
Further cooling gave the previously noted needles at 104 °C. Reheating brought about
a nematic to isotropic transition at 113.5 °C (Figure 49). It was found that there was a
crystal to crystal transformation (fanshape crystals to small rhombic crystals) at 89.9
– 92.2 °C (Figure 50). This transformation seems to correspond to the signal seen at
about 83 °C in the DSC heating cycle for the compound. At 102.3 °C – 104 °C, the
small rhombic crystals changed to the previously observed needles (Figure 51). A
contact with 4-heptylcyano-phenylcyclohexane (PCH-7) induced a smectic phase
(SmA) (Figure 52). The contact showed a higher isotropic point than PCH-7 alone. A
contact with cholesteryl esters induced a cholesteric phase, where pitch of the helix
was only slightly temperature dependent.

Figure 49: Nematic phase of compound 24 at 112.7 °C (Schlieren
texture), 1st cycle, cooling
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Figure 50: Change of fan-shape crystals to smaller crystals at 89.992.2 °C of compound 24

Figure 51: Needle shape of crystal of compound 24
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Figure 52: Contact with PCH-7: induction of a SmA phase (at 90 °C
of compound 24, picture taken under quick cooling)

Figure 53: Contact with cholesteryl esters: induction of a cholesteric
phase of compound 24
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3.4.2 Thermotropic behavior of compound 42
The compound 42 which is one the series of the Cholesteryl azo ethers, exhibit
thermotropic behavior. The results of the POMHS show a chiral nematic mesophase
during the cooling cycle. When the (PCH-7) was added to the texture as a dopant, the
helical pitch was increased (Figure 54).

Figure 54: Chiral helical phase with large pitch at upper left hand corner
(PCH-7) transforming into helical phase with smaller pitch as you go
downwards (increasing the conc. of 42)
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Chapter 4: Conclusion

In conclusion, the target compounds could be synthesized successfully. The
synthesized compounds have been characterized by 1H NMR, 13C NMR, DEPT, IRspectroscopy, LC-MS-MS and UV-spectroscopy. Key steps en route to the target
compounds

were

diazotization,

Appel-type

esterification

and

Williamson

etherification.
The photoswitching behavior of the compounds was investigated using UVspectroscopy and 1H NMR spectroscopy. It could be seen that cis-trans isomerization
of the azo functionality could be triggered selectively in the presence of a cinnamate
function. In some cases, substitution patterns on the cinnamate moiety changed the
position of λmax of the cinnamate moiety and sometimes shifted the absorption band
towards higher wavelength, causing an overlap with the azobenzene absorption band,
which affected the selectivity of the trans-cis isomerization of the azo moiety. The time
for the thermal reversion after photoirradiation was dependent on the structure of the
compound, ie., the substitution pattern of the cinnamate and the chain lengths within
the compounds.
The thermal behavior of the compounds was investigated using differential
scanning calorimeter “DSC”, and the DSC results showed more than one transition for
all azo-cinnamate compounds in the cooling phase except for compound 26. Also, the
textural changes were investigated using a polarized light microscope with a hot stage.
These results indicate that most of the azo-cinnamates compounds could exhibit
thermotropic behavior.
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From the optical microscopy analysis, it can be said that apart from anthryl
compound 26, the azo-cinnamates show an isotropic to nematic transition upon
cooling. The 3,4-dimethoxycinnamates show an additional smectic A phase as could
be evidenced by the behavior of compound 36. Contacts with PCH-7 led in certain
cases to the induction of a smectic A phase also in those compounds that only showed
a nematic phase in their pure state, such as compound 24. Cholesteryl azo ether 42
showed a reentrant chiral nematic phase.
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Figure 55: 1H, 13C NMR of compound 12
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Figure 56: 1H, 13C NMR of compound 13
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Figure 57: 1H, 13C NMR of compound 17
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Figure 58: 1H, 13C NMR of compound 18

2.0

40

1.5

30

1.0

20

10

95

8.0

7.5

160

150

7.0

140

6.5

130

6.0

120

5.5

110

5.0

100

4.5

90

4.0

80

3.5

70

3.0

60

2.5

50

2.0

40

1.5

30

1.0

20

10

Figure 59: 1H, 13C NMR of compound 19
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Figure 60: 1H, 13C NMR of compound 20
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Figure 61: 1H, 13C NMR of compound 21
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Figure 62: 1H, 13C NMR of compound 22
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Figure 63: 1H, 13C NMR of compound 23
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Figure 64: 1H, 13C of NMR compound 24
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Figure 65: 1H, 13C NMR of compound 25
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Figure 66: 1H, 13C NMR of compound 26
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Figure 67: 1H, 13C NMR of compound 27
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Figure 68: 1H, 13C NMR of compound 28
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Figure 69: 1H, 13C NMR of compound 29
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Figure 70: 1H, 13C NMR of compound 30

2.0

40

1.5

30

1.0

20

10

101

8.0

7.5

170

7.0

160

150

6.5

6.0

140

130

5.5

120

5.0

110

4.5

100

90

4.0

3.5

80

70

3.0

60

2.5

50

2.0

40

1.5

30

1.0

20

10

Figure 71: 1H, 13C NMR of compound 31
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Figure 72: 1H, 13C NMR of compound 32
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Figure 73: 1H, 13C NMR of compound 33
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Figure 74: 1H, 13C NMR of compound 34
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Figure 75: 1H, 13C NMR of compound 35

8.0

170

7.5

160

7.0

150

6.5

140

6.0

130

5.5

120

5.0

110

4.5

100

4.0

90

3.5

80

70

3.0

60

2.5

50

Figure 76: 1H, 13C NMR of compound 36
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Figure 77: 1H, 13C NMR of compound 37
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Figure 78: 1H, 13C NMR of compound 38
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Figure 79: 1H, 13C NMR of compound 39

CH3 carbon

CH2 carbon

CH carbon

Quaternary carbon

Figure 80: DEPT NMR of compound 39
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Table 2: list of the 13C peaks of the DEPT NMR of compound 39
Quaternary

(CH) carbon

(CH2) carbon

(CH3) carbon

36.89 (C)

28.01 (CH)

21.05 (CH2)

11.85 (CH3)

42.29 (C)

31.87 (CH)

22.57 (CH2)

14.06 (CH3)

141.13 (C)

35.79 (CH)

23.82 (CH2)

18.70 (CH3)

146.87 (C)

50.17 (CH)

24.28 (CH2)

19.38 (CH3)

161.11 (C)

56.12 (CH)

25.71 (CH2)

22.61 (CH3)

56.75 (CH)

25.98 (CH2)

22.83 (CH3)

78.94 (CH)

26.18 (CH2)

114.60 (CH)

28.23 (CH2)

121.39 (CH)

28.48 (CH2)

124.27(CH)

29.18 (CH2)

Carbon (C)

29.28 (CH2)
29.38 (CH2)
29.47 (CH2)
29.71 (CH2)
30.18 (CH2)
31.58 (CH2)
31.93 (CH2)
36.17 (CH2)
37.28 (CH2)
39.20 (CH2)
39.50 (CH2)
39.76 (CH2)
68.10 (CH2)
68.26 (CH2)
68.28 (CH2)
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Figure 81: 1H, 13C NMR of compound 40
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Figure 82: 1H, 13C NMR of compound 41
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Figure 83: 1H, 13C NMR of compound 42
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